BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ostapowicz G. Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States. Ann Intern Med 2002;137:947. [DOI: 10.7326/0003-4819-137-12-200212170-00007] [Cited by in Crossref: 1426] [Cited by in F6Publishing: 1137] [Article Influence: 75.1] [Reference Citation Analysis]
Number Citing Articles
1 Gow P, Hathaway M, Gunson B, Heward J, Mutimer D. Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3. J Gastroenterol Hepatol 2005;20:555-61. [DOI: 10.1111/j.1440-1746.2005.03605.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
2 Atienzar FA, Blomme EA, Chen M, Hewitt P, Kenna JG, Labbe G, Moulin F, Pognan F, Roth AB, Suter-Dick L, Ukairo O, Weaver RJ, Will Y, Dambach DM. Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. Biomed Res Int 2016;2016:9737920. [PMID: 27689095 DOI: 10.1155/2016/9737920] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
3 Tan YL, Ho HK. Hypothermia Advocates Functional Mitochondria and Alleviates Oxidative Stress to Combat Acetaminophen-Induced Hepatotoxicity. Cells 2020;9:E2354. [PMID: 33114500 DOI: 10.3390/cells9112354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lorincz MT. Wilson disease and related copper disorders. Neurogenetics, Part I. Elsevier; 2018. pp. 279-92. [DOI: 10.1016/b978-0-444-63233-3.00018-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 7.3] [Reference Citation Analysis]
5 Lee WM. Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away? J Hepatol. 2017;67:1324-1331. [PMID: 28734939 DOI: 10.1016/j.jhep.2017.07.005] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 28.0] [Reference Citation Analysis]
6 Björnsson E, Kalaitzakis E, Av Klinteberg V, Alem N, Olsson R. Long-term follow-up of patients with mild to moderate drug-induced liver injury. Aliment Pharmacol Ther 2007;26:79-85. [PMID: 17555424 DOI: 10.1111/j.1365-2036.2007.03355.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
7 Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH. Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Liver Int 2011;31:499-506. [PMID: 21382160 DOI: 10.1111/j.1478-3231.2011.02450.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
8 Richards JA, Bucsaiova M, Hesketh EE, Ventre C, Henderson NC, Simpson K, Bellamy CO, Howie SE, Anderton SM, Hughes J, Wigmore SJ. Acute Liver Injury Is Independent of B Cells or Immunoglobulin M. PLoS One 2015;10:e0138688. [PMID: 26406765 DOI: 10.1371/journal.pone.0138688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Basta G, Del Turco S, Navarra T, Lee WM; Acute Liver Failure Study Group. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure. Liver Transpl 2015;21:847-54. [PMID: 25825217 DOI: 10.1002/lt.24129] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
10 Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol. 2010;369-405. [PMID: 20020268 DOI: 10.1007/978-3-642-00663-0_12] [Cited by in Crossref: 498] [Cited by in F6Publishing: 423] [Article Influence: 45.3] [Reference Citation Analysis]
11 Singhal S, Kohaar I, Bharadwaj M, Shukla DK, Das BC, Kar P. Association of Tumor Necrosis Factor-Alpha Gene Promoter Polymorphisms with Acute Viral Hepatitis in the Indian Population. Dig Dis Sci 2010;55:1106-12. [DOI: 10.1007/s10620-009-0799-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Joshi GP. Valdecoxib for the management of chronic and acute pain. Expert Review of Neurotherapeutics 2014;5:11-24. [DOI: 10.1586/14737175.5.1.11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Andrade RJ, Lucena MI. Drug Induced Liver Disease: Mechanisms and Diagnosis. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 771-86. [DOI: 10.1002/9781444314403.ch47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol. 2004;99:950-952. [PMID: 15128366 DOI: 10.1111/j.1572-0241.2004.04165.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
15 Wree A, Dechêne A, Herzer K, Hilgard P, Syn WK, Gerken G, Canbay A. Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury. Digestion 2011;84:54-9. [PMID: 21304237 DOI: 10.1159/000322298] [Cited by in F6Publishing: 40] [Reference Citation Analysis]
16 Duffy J, Padovani F, Brunetti G, Noy P, Certa U, Hegner M. Towards personalised rapid label free miRNA detection for cancer and liver injury diagnostics in cell lysates and blood based samples. Nanoscale 2018;10:12797-804. [PMID: 29947396 DOI: 10.1039/c8nr03604g] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
17 Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009;41:816-819. [PMID: 19483685 DOI: 10.1038/ng.379] [Cited by in Crossref: 749] [Cited by in F6Publishing: 592] [Article Influence: 62.4] [Reference Citation Analysis]
18 Kalsi SS, Wood DM, Waring WS, Dargan PI. Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose? Open Access Emerg Med 2011;3:69-76. [PMID: 27147854 DOI: 10.2147/OAEM.S24962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
19 Bleibel W, Kim S, D’silva K, Lemmer ER. Drug-Induced Liver Injury: Review Article. Dig Dis Sci 2007;52:2463-71. [DOI: 10.1007/s10620-006-9472-y] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
20 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401-1415. [PMID: 18318440 DOI: 10.1002/hep.22177] [Cited by in Crossref: 442] [Cited by in F6Publishing: 378] [Article Influence: 34.0] [Reference Citation Analysis]
21 Green TJ, Sivilotti ML, Langmann C, Yarema M, Juurlink D, Burns MJ, Johnson DW. When do the aminotransferases rise after acute acetaminophen overdose? Clinical Toxicology 2010;48:787-92. [DOI: 10.3109/15563650.2010.523828] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
22 Blackmore L, Bernal W. Acute liver failure. Clin Med (Lond) 2015;15:468-72. [PMID: 26430188 DOI: 10.7861/clinmedicine.15-5-468] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lee CH, Wang JD, Chen PC; Health Data Analysis in Taiwan (hDATa) Research Group. Case-crossover design: an alternative strategy for detecting drug-induced liver injury. J Clin Epidemiol 2012;65:560-7. [PMID: 22445086 DOI: 10.1016/j.jclinepi.2011.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
24 Karkhanis J, Verna EC, Chang MS, Stravitz RT, Schilsky M, Lee WM, Brown RS; Acute Liver Failure Study Group. Steroid use in acute liver failure. Hepatology. 2014;59:612-621. [PMID: 23929808 DOI: 10.1002/hep.26678] [Cited by in Crossref: 108] [Cited by in F6Publishing: 93] [Article Influence: 13.5] [Reference Citation Analysis]
25 Min Z, Gnann JW. Kaposi’s varicelliform eruption. Intern Emerg Med 2014;9:101-2. [DOI: 10.1007/s11739-013-1001-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
26 Singh S, Hynan LS, Rule JA, Lee WM. Changes in alpha-foetoprotein and Gc-globulin in relation to outcomes in non-acetaminophen acute liver failure. Liver Int 2019;39:2368-73. [PMID: 31421008 DOI: 10.1111/liv.14216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Punch JD. Bridges to transplantation. Anesthesiol Clin North Am 2004;22:863-9. [PMID: 15541939 DOI: 10.1016/j.atc.2004.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
28 Wong A, Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clinical Toxicology 2015;54:115-9. [DOI: 10.3109/15563650.2015.1115055] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
29 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
30 Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data: DRUG-ASSOCIATED LIVER INJURY. Pharmacoepidemiol Drug Saf 2013;22:190-8. [DOI: 10.1002/pds.3388] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
31 Jhang JS, Schilsky ML, Lefkowitch JH, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease. J Clin Apher. 2007;22:10-14. [PMID: 17285615 DOI: 10.1002/jca.20118] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
32 Schilsky ML. Acute liver failure and liver assist devices. Transplant Proc 2011;43:879-83. [PMID: 21486619 DOI: 10.1016/j.transproceed.2011.01.109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
33 Shumar J, Ordway S, Junga Z, Sadowski B, Torres D. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM). ACG Case Rep J 2019;6:e00184. [PMID: 31737715 DOI: 10.14309/crj.0000000000000184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
34 Björnsson ES. Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury. Clin Liver Dis 2020;24:1-10. [PMID: 31753242 DOI: 10.1016/j.cld.2019.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
35 Saithanyamurthi H, Faust AJ. Drug-Induced Liver Disease: Clinical Course. Clin Liver Dis 2017;21:21-34. [PMID: 27842773 DOI: 10.1016/j.cld.2016.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
36 Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138:2246-2259. [PMID: 20394749 DOI: 10.1053/j.gastro.2010.04.001] [Cited by in Crossref: 202] [Cited by in F6Publishing: 169] [Article Influence: 18.4] [Reference Citation Analysis]
37 Felser A, Lindinger PW, Schnell D, Kratschmar DV, Odermatt A, Mies S, Jenö P, Krähenbühl S. Hepatocellular toxicity of benzbromarone: effects on mitochondrial function and structure. Toxicology 2014;324:136-46. [PMID: 25108121 DOI: 10.1016/j.tox.2014.08.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
38 Heaton PC, Cluxton RJ, Moomaw CJ. Acetaminophen Overuse in the Ohio Medicaid Population. Journal of the American Pharmacists Association 2003;43:680-4. [DOI: 10.1331/154434503322642606] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
39 Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: A curable disease by 2024? J Hepatol. 2015;62:S112-S120. [PMID: 25920080 DOI: 10.1016/j.jhep.2014.12.016] [Cited by in Crossref: 130] [Cited by in F6Publishing: 100] [Article Influence: 26.0] [Reference Citation Analysis]
40 Kurokohchi K, Imataki O, Kubo F. Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure. World J Gastroenterol 2015;21:8203-7. [PMID: 26185395 DOI: 10.3748/wjg.v21.i26.8203] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Antoine DJ, Williams DP, Park BK. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science. Expert Opin Drug Metab Toxicol 2008;4:1415-27. [PMID: 18950283 DOI: 10.1517/17425255.4.11.1415] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
42 Lewis JH. 'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective. Pharmacoepidemiol Drug Saf 2006;15:221-9. [PMID: 16444771 DOI: 10.1002/pds.1209] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
43 Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814-821. [PMID: 17370333 DOI: 10.1002/lt.21050] [Cited by in Crossref: 97] [Cited by in F6Publishing: 71] [Article Influence: 6.9] [Reference Citation Analysis]
44 Munoz SJ, Rajender Reddy K, Lee W. The coagulopathy of acute liver failure and implications for intracranial pressure monitoring. Neurocrit Care. 2008;9:103-107. [PMID: 18379899 DOI: 10.1007/s12028-008-9087-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
45 Mitchell SJ, Kane AE, Hilmer SN. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res 2011;2011:624156. [PMID: 21765826 DOI: 10.1155/2011/624156] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
46 Shaw PJ, Ditewig AC, Waring JF, Liguori MJ, Blomme EA, Ganey PE, Roth RA. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. Toxicol Sci 2009;107:270-80. [PMID: 18930950 DOI: 10.1093/toxsci/kfn205] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
47 Kwekel JC, Desai VG, Moland CL, Branham WS, Fuscoe JC. Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics 2010;11:675. [PMID: 21118493 DOI: 10.1186/1471-2164-11-675] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
48 Tsaroucha A, Chondrogiannis C, Mani A, Staikou C. Myocardial involvement during ischemia-induced acute liver failure in the pig. J Invest Surg 2013;26:99-104. [PMID: 23273174 DOI: 10.3109/08941939.2012.705953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Lee WM, Seremba E. Etiologies of acute liver failure. Curr Opin Crit Care 2008;14:198-201. [PMID: 18388683 DOI: 10.1097/MCC.0b013e3282f6a420] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
50 Loosen SH, Schueller F, Trautwein C, Roy S, Roderburg C. Role of circulating microRNAs in liver diseases. World J Hepatol. 2017;9:586-594. [PMID: 28515844 DOI: 10.4254/wjh.v9.i12.586] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
51 Urrunaga NH, Rachakonda VP, Magder LS, Mindikoglu AL. Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014;46:219-224. [PMID: 24507055 DOI: 10.1016/j.transproceed.2013.08.111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
52 Lee WM, Polson J. Analyzing liver transplantation for fulminant hepatic failure at UCLA: A retrospective look at 18 years' experience. Liver Transpl 2004;10:953-5. [DOI: 10.1002/lt.20151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Stumpf JL, Skyles AJ, Alaniz C, Erickson SR. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. Journal of the American Pharmacists Association 2007;47:35-41. [DOI: 10.1331/1544-3191.47.1.35.stumpf] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
54 Shinohara M, Ybanez MD, Win S, Than TA, Jain S, Gaarde WA, Han D, Kaplowitz N. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem 2010;285:8244-55. [PMID: 20061376 DOI: 10.1074/jbc.M109.054999] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
55 Khanna A, Hemming AW. Fulminant hepatic failure: when to transplant. Surg Clin North Am 2010;90:877-89. [PMID: 20637954 DOI: 10.1016/j.suc.2010.04.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
56 Anwar I, Ashfaq UA, Shokat Z. Therapeutic Potential of Umbilical Cord Stem Cells for Liver Regeneration. Curr Stem Cell Res Ther 2020;15:219-32. [PMID: 32077830 DOI: 10.2174/1568026620666200220122536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Brophy CM, Nyberg SL. Extracorporeal treatment of acute liver failure. Hepatol Res 2008;38 Suppl 1:S34-40. [PMID: 19125950 DOI: 10.1111/j.1872-034X.2008.00424.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
58 Uetrecht J. Role of the Adaptive Immune System in Idiosyncratic Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 175-93. [DOI: 10.1016/b978-0-12-387817-5.00011-x] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
59 Wong A, Sivilotti MLA, Dargan PI, Wood DM, Greene SL. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clinical Toxicology 2015;53:807-14. [DOI: 10.3109/15563650.2015.1066507] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
60 Li X, Gao P, Niu J. Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. Biomed Res Int 2019;2019:8764093. [PMID: 31531370 DOI: 10.1155/2019/8764093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Jennings P, Schwarz M, Landesmann B, Maggioni S, Goumenou M, Bower D, Leonard MO, Wiseman JS. SEURAT-1 liver gold reference compounds: a mechanism-based review. Arch Toxicol 2014;88:2099-133. [DOI: 10.1007/s00204-014-1410-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
62 Shi Y, Zhang L, Jiang R, Chen W, Zheng W, Chen L, Tang L, Li L, Li L, Tang W, Wang Y, Yu Y. Protective effects of nicotinamide against acetaminophen-induced acute liver injury. Int Immunopharmacol 2012;14:530-7. [PMID: 23059795 DOI: 10.1016/j.intimp.2012.09.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
63 Andersson U, Yang H, Harris H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets 2018;22:263-77. [PMID: 29447008 DOI: 10.1080/14728222.2018.1439924] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 34.0] [Reference Citation Analysis]
64 Kwong S, Meyerson C, Zheng W, Kassardjian A, Stanzione N, Zhang K, Wang HL. Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis. Semin Diagn Pathol 2019;36:404-14. [PMID: 31405537 DOI: 10.1053/j.semdp.2019.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
65 Wong A, Graudins A. N-acetylcysteine regimens for paracetamol overdose: Time for a change?: N-acetylcysteine for Paracetamol Overdose. Emergency Medicine Australasia 2016;28:749-51. [DOI: 10.1111/1742-6723.12610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
66 Shamseddeen H, Vilar-Gomez E, Chalasani N, Myers RP, Subramanian GM, Shlevin HH, Allgood AE, Orman ES. Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring. Drug Saf 2020;43:281-90. [PMID: 31907854 DOI: 10.1007/s40264-019-00896-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197. [PMID: 15841455 DOI: 10.1002/hep.20703] [Cited by in Crossref: 603] [Cited by in F6Publishing: 491] [Article Influence: 37.7] [Reference Citation Analysis]
68 Liu C, Fan H, Li Y, Xiao X. Research Advances on Hepatotoxicity of Herbal Medicines in China. Biomed Res Int 2016;2016:7150391. [PMID: 28078299 DOI: 10.1155/2016/7150391] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
69 Lee WM. Acetaminophen Toxicity: A History of Serendipity and Unintended Consequences. Clin Liver Dis (Hoboken) 2020;16:34-44. [PMID: 33042525 DOI: 10.1002/cld.984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 McMillin M, Grant S, Frampton G, Andry S, Brown A, DeMorrow S. Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. J Neuroinflammation. 2016;13:198. [PMID: 27561705 DOI: 10.1186/s12974-016-0674-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
71 Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14 Suppl 2:S67-S79. [PMID: 18825677 DOI: 10.1002/lt.21612] [Cited by in Crossref: 126] [Cited by in F6Publishing: 92] [Article Influence: 10.5] [Reference Citation Analysis]
72 Kim AI, Han S, Tran D, Sullivan P, Lassman C, Raman S, Zimmerman P, Chin EE. Abdominal imaging can misdiagnose submassive hepatic necrosis as cirrhosis in acute liver failure. Clin Transplant 2013;27:E339-45. [DOI: 10.1111/ctr.12123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
73 Cornwell PD, Ulrich RG. Investigating the Mechanistic Basis for Hepatic Toxicity Induced by an Experimental Chemokine Receptor 5 (CCR5) Antagonist Using a Compendium of Gene Expression Profiles. Toxicol Pathol 2007;35:576-88. [DOI: 10.1080/01926230701383194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
74 McMillin M, Frampton G, Quinn M, Ashfaq S, de los Santos M 3rd, Grant S, DeMorrow S. Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. Am J Pathol 2016;186:312-23. [PMID: 26683664 DOI: 10.1016/j.ajpath.2015.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
75 Losanoff JE, Holder-murray JM, Ahmed EB, Cochrane AB, Testa G, Millis JM. Minocycline Toxicity Requiring Liver Transplant. Dig Dis Sci 2007;52:3242-4. [DOI: 10.1007/s10620-006-9550-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
76 Bernuau J. Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. Journal of Hepatology 2004;41:152-5. [DOI: 10.1016/j.jhep.2004.05.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
77 Lee GH, Lee HY, Choi MK, Chung HW, Kim SW, Chae HJ. Protective effect of Curcuma longa L. extract on CCl4-induced acute hepatic stress. BMC Res Notes 2017;10:77. [PMID: 28143589 DOI: 10.1186/s13104-017-2409-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
78 Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci. 2010;115:307-321. [PMID: 20071422 DOI: 10.1093/toxsci/kfq009] [Cited by in Crossref: 201] [Cited by in F6Publishing: 166] [Article Influence: 18.3] [Reference Citation Analysis]
79 Ghosh A, Berger I, Remien CH, Mubayi A. The role of alcohol consumption on acetaminophen induced liver injury: Implications from a mathematical model. J Theor Biol 2021;519:110559. [PMID: 33333080 DOI: 10.1016/j.jtbi.2020.110559] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Zhang Y, Zhou ZW, Jin H, Hu C, He ZX, Yu ZL, Ko KM, Yang T, Zhang X, Pan SY, Zhou SF. Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity. Drug Des Devel Ther 2015;9:2001-27. [PMID: 25926716 DOI: 10.2147/DDDT.S77071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
81 Yeboah-Korang A, Louissaint J, Tsung I, Prabhu S, Fontana RJ. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record. Drug Saf 2020;43:371-7. [PMID: 31916081 DOI: 10.1007/s40264-019-00903-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
82 Mohi-Ud-Din R, Mir RH, Sawhney G, Dar MA, Bhat ZA. Possible Pathways of Hepatotoxicity Caused by Chemical Agents. Curr Drug Metab 2019;20:867-79. [PMID: 31702487 DOI: 10.2174/1389200220666191105121653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
83 Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol. 2005;17:445-447. [PMID: 15756098 DOI: 10.1097/00042737-200504000-00009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
84 Doyon S, Klein-schwartz W, Lee S, Beuhler MC. Fatalities involving acetaminophen combination products reported to United States poison centers. Clinical Toxicology 2013;51:941-8. [DOI: 10.3109/15563650.2013.848282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
85 Hamdi T, Yessayan L, Yee J, Szamosfalvi B. High sodium continuous veno-venous hemodialysis with regional citrate anticoagulation and online dialysate generation in patients with acute liver failure and cerebral edema: High sodium CVVHD-RCA for cerebral edema. Hemodialysis International 2018;22:184-91. [DOI: 10.1111/hdi.12572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
86 Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure. Clin Gastroenterol Hepatol. 2016;14:1199-1206.e2. [PMID: 27085756 DOI: 10.1016/j.cgh.2016.03.046] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
87 Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. Liver Int 2021. [PMID: 34152686 DOI: 10.1111/liv.14985] [Reference Citation Analysis]
88 Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, Rela M, Heaton N, O'Grady JG, Wendon J, Williams R. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74-80. [PMID: 23439263 DOI: 10.1016/j.jhep.2013.02.010] [Cited by in Crossref: 235] [Cited by in F6Publishing: 184] [Article Influence: 29.4] [Reference Citation Analysis]
89 Simpson KJ, Bates CM, Henderson NC, Wigmore SJ, Garden OJ, Lee A, Pollok A, Masterton G, Hayes PC. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl. 2009;15:600-609. [PMID: 19479803 DOI: 10.1002/lt.21681] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
90 Beggs KM, Fullerton AM, Miyakawa K, Ganey PE, Roth RA. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction. Toxicol Sci 2014;137:91-101. [PMID: 24097668 DOI: 10.1093/toxsci/kft226] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
91 Muhammad-Azam F, Nur-Fazila SH, Ain-Fatin R, Mustapha Noordin M, Yimer N. Histopathological changes of acetaminophen-induced liver injury and subsequent liver regeneration in BALB/C and ICR mice. Vet World 2019;12:1682-8. [PMID: 32009746 DOI: 10.14202/vetworld.2019.1682-1688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Urrunaga NH, Magder LS, Weir MR, Rockey DC, Mindikoglu AL. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci 2016;61:309-16. [PMID: 26386861 DOI: 10.1007/s10620-015-3870-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
93 Dara L, Liu Z, Kaplowitz N. Pathogenesis of Idiosyncratic Drug Induced Liver Injury. Liver Pathophysiology. Elsevier; 2017. pp. 87-100. [DOI: 10.1016/b978-0-12-804274-8.00005-9] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
94 Muriel P. The Liver. Liver Pathophysiology. Elsevier; 2017. pp. 3-22. [DOI: 10.1016/b978-0-12-804274-8.00001-1] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
95 Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703. [PMID: 21624500 DOI: 10.1016/j.drudis.2011.05.007] [Cited by in Crossref: 245] [Cited by in F6Publishing: 199] [Article Influence: 24.5] [Reference Citation Analysis]
96 Ahmed NZ, Agibothu Kupparam HK, Akbar S, Hissar S, Anwar N, Thiruvengadam K, Anjum N, Khan AA, Dar S, Natarajan S. Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats. J Complement Integr Med 2021. [PMID: 33964191 DOI: 10.1515/jcim-2020-0262] [Reference Citation Analysis]
97 Fontana RJ. Should aciclovir be given to all patients presenting with acute liver failure of unknown etiology? Nat Clin Pract Gastroenterol Hepatol 2008;5:298-9. [PMID: 18477988 DOI: 10.1038/ncpgasthep1128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
98 Renner EL. How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King’s College criteria, or something else? Journal of Hepatology 2007;46:554-7. [DOI: 10.1016/j.jhep.2007.01.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
99 Au SH, Chamberlain MD, Mahesh S, Sefton MV, Wheeler AR. Hepatic organoids for microfluidic drug screening. Lab Chip. 2014;14:3290-3299. [PMID: 24984750 DOI: 10.1039/c4lc00531g] [Cited by in Crossref: 93] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
100 Ganger DR, Rule J, Rakela J, Bass N, Reuben A, Stravitz RT, Sussman N, Larson AM, James L, Chiu C, Lee WM; Acute Liver Failure Study Group. Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality. Am J Gastroenterol 2018;113:1319. [PMID: 29946176 DOI: 10.1038/s41395-018-0160-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
101 Kartiko S, Ortiz J, Hashemi N, Miick R, Dallal R. Acute liver failure complicating jejunojejunal intussusception presentation in a gastric bypass patient. World J Hepatol 2012;4:311-3. [PMID: 23293717 DOI: 10.4254/wjh.v4.i11.311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
102 Pais R, Rusu E, Ratziu V. The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. Clin Liver Dis. 2014;18:165-178. [PMID: 24274872 DOI: 10.1016/j.cld.2013.09.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
103 Lee WM, Wijdicks EF. Fulminant hepatic failure: when the hepatologist meets the neurointensivist. Neurocrit Care 2008;9:1-2. [PMID: 18425603 DOI: 10.1007/s12028-008-9079-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
104 Lundbäck P, Lea JD, Sowinska A, Ottosson L, Fürst CM, Steen J, Aulin C, Clarke JI, Kipar A, Klevenvall L, Yang H, Palmblad K, Park BK, Tracey KJ, Blom AM, Andersson U, Antoine DJ, Erlandsson Harris H. A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice. Hepatology 2016;64:1699-710. [PMID: 27474782 DOI: 10.1002/hep.28736] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 13.6] [Reference Citation Analysis]
105 Namn Y, Schneider Y, Cui IH, Jesudian A. Diphenhydramine as a Cause of Drug-Induced Liver Injury. Case Reports Hepatol 2017;2017:3864236. [PMID: 28246565 DOI: 10.1155/2017/3864236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Hayashi PH, Rockey DC, Fontana RJ, Tillmann HL, Kaplowitz N, Barnhart HX, Gu J, Chalasani NP, Reddy KR, Sherker AH, Hoofnagle JH;  Drug-Induced Liver Injury Network (DILIN) Investigators. Death and liver transplantation within 2 years of onset of drug-induced liver injury. Hepatology. 2017;66:1275-1285. [PMID: 28543844 DOI: 10.1002/hep.29283] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
107 De Wolf AM. Preoperative optimization of patients with liver disease. Current Opinion in Anaesthesiology 2005;18:325-31. [DOI: 10.1097/01.aco.0000169242.03754.cc] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
108 Donati M, Conforti A, Lenti MC, Capuano A, Bortolami O, Motola D, Moretti U, Vannacci A, Rafaniello C, Vaccheri A, Arzenton E, Bonaiuti R, Sportiello L, Leone R; DILI-IT Study Group. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. Br J Clin Pharmacol 2016;82:238-48. [PMID: 26991794 DOI: 10.1111/bcp.12938] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
109 Jiang F, Yan H, Liang L, Du J, Jin S, Yang S, Wang H, Hu T, Zhu Y, Wang G, Hu Y, Cai T, Aithal GP. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients. Liver Int 2021;41:1565-75. [PMID: 33866661 DOI: 10.1111/liv.14896] [Reference Citation Analysis]
110 Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P. Apoptotic Mechanisms in Fulminant Hepatic Failure: Potential Therapeutic Target. Applied Immunohistochemistry & Molecular Morphology 2009;17:282-5. [DOI: 10.1097/pai.0b013e3181906f6d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Poulsen KL, Albee RP, Ganey PE, Roth RA. Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase. J Pharmacol Exp Ther 2014;349:185-91. [PMID: 24525298 DOI: 10.1124/jpet.113.211276] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
112 Bai L, Liu X, Zheng Q, Kong M, Zhang X, Hu R, Lou J, Ren F, Chen Y, Zheng S, Liu S, Han YP, Duan Z, Pandol SJ. M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes. Sci Rep 2017;7:10518. [PMID: 28874845 DOI: 10.1038/s41598-017-11303-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
113 Rosenblatt R, Brown RS. Nonviral or Drug-Induced Etiologies of Acute Liver Failure. Clinics in Liver Disease 2018;22:347-60. [DOI: 10.1016/j.cld.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
114 Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis. 2007;11:459-475, v. [PMID: 17723915 DOI: 10.1016/j.cld.2007.06.001] [Cited by in Crossref: 107] [Cited by in F6Publishing: 82] [Article Influence: 7.6] [Reference Citation Analysis]
115 Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology. 2014;60:1015-1022. [PMID: 24799086 DOI: 10.1002/hep.27206] [Cited by in Crossref: 150] [Cited by in F6Publishing: 118] [Article Influence: 21.4] [Reference Citation Analysis]
116 Stine JG, Sateesh P, Lewis JH. Drug-induced liver injury in the elderly. Curr Gastroenterol Rep. 2013;15:299. [PMID: 23250699 DOI: 10.1007/s11894-012-0299-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
117 Zhao ZW, Chang JC, Lin LW, Tsai FH, Chang HC, Wu CR. Comparison of the Hepatoprotective Effects of Four Endemic Cirsium Species Extracts from Taiwan on CCl₄-Induced Acute Liver Damage in C57BL/6 Mice. Int J Mol Sci 2018;19:E1329. [PMID: 29710853 DOI: 10.3390/ijms19051329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
118 Kaur I, Singh J. Cholestatic hepatitis with intravenous ceftriaxone. Indian J Pharmacol 2011;43:474-5. [PMID: 21845011 DOI: 10.4103/0253-7613.83133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
119 Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. Species differences in bile acids II. Bile acid metabolism. J Appl Toxicol. 2018;38:1336-1352. [PMID: 29845631 DOI: 10.1002/jat.3645] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
120 Areia M, Romãozinho JM, Ferreira M, Amaro P, Leitão MC. Fulminant hepatic failure: a Portuguese experience. Eur J Gastroenterol Hepatol 2007;19:665-9. [PMID: 17625436 DOI: 10.1097/MEG.0b013e3281ac20da] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
121 Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ 2nd, Murray NG, McCashland T, Reisch JS, Robuck PR;  Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-864, 864. e1. [PMID: 19524577 DOI: 10.1053/j.gastro.2009.06.006] [Cited by in Crossref: 402] [Cited by in F6Publishing: 279] [Article Influence: 33.5] [Reference Citation Analysis]
122 Ma Q, Lu AYH, Sibley DR. Pharmacogenetics, Pharmacogenomics, and Individualized Medicine. Pharmacol Rev 2011;63:437-59. [DOI: 10.1124/pr.110.003533] [Cited by in Crossref: 301] [Cited by in F6Publishing: 206] [Article Influence: 30.1] [Reference Citation Analysis]
123 Devarbhavi H, Patil M, Reddy VV, Singh R, Joseph T, Ganga D. Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients. Liver Int 2018;38:1322-9. [DOI: 10.1111/liv.13662] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
124 McIntyre RS, Panjwani ZD, Nguyen HT, Woldeyohannes HO, Alsuwaidan M, Soczynska JK, Lourenco MT, Konarski JZ, Kennedy SH. The hepatic safety profile of duloxetine: a review. Expert Opin Drug Metab Toxicol. 2008;4:281-285. [PMID: 18363543 DOI: 10.1517/17425255.4.3.281] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
125 Alauddin, Chaturvedi S, Malik MY, Azmi L, Shukla I, Naseem Z, Rao C, Agarwal NK. Formononetin and biochanin A protects against ritonavir induced hepatotoxicity via modulation of NfκB/pAkt signaling molecules. Life Sciences 2018;213:174-82. [DOI: 10.1016/j.lfs.2018.10.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
126 Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol. 2011;8:202-211. [PMID: 21386809 DOI: 10.1038/nrgastro.2011.22] [Cited by in Crossref: 166] [Cited by in F6Publishing: 139] [Article Influence: 16.6] [Reference Citation Analysis]
127 Sedky K, Nazir R, Joshi A, Kaur G, Lippmann S. Which psychotropic medications induce hepatotoxicity? General Hospital Psychiatry 2012;34:53-61. [DOI: 10.1016/j.genhosppsych.2011.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
128 Suzuki A, Andrade RJ, Bjornsson E, Lucena MI, Lee WM, Yuen NA, Hunt CM, Freston JW. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf. 2010;33:503-522. [PMID: 20486732 DOI: 10.2165/11535340-000000000-00000] [Cited by in Crossref: 112] [Cited by in F6Publishing: 91] [Article Influence: 10.2] [Reference Citation Analysis]
129 Feng R, Wang Y, Liu C, Yan C, Zhang H, Su H, Kang JX, Shang C, Wan J. Acetaminophen-induced liver injury is attenuated in transgenic fat-1 mice endogenously synthesizing long-chain n-3 fatty acids. Biochemical Pharmacology 2018;154:75-88. [DOI: 10.1016/j.bcp.2018.04.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
130 Vuppalanchi R. Drug-Induced Liver Injury. In: Saeian K, Shaker R, editors. Liver Disorders. Cham: Springer International Publishing; 2017. pp. 389-403. [DOI: 10.1007/978-3-319-30103-7_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
131 Louvet A, Boitard J, Dharancy S, Duriez A, Deltenre P, Paris J, Mathurin P. La mésaventure thérapeutique du paracétamol chez le buveur excessif. Gastroentérologie Clinique et Biologique 2006;30:769-74. [DOI: 10.1016/s0399-8320(06)73312-7] [Cited by in Crossref: 10] [Article Influence: 0.7] [Reference Citation Analysis]
132 Kennedy M, Alexopoulos SP. Hepatitis B virus infection and liver transplantation: . Current Opinion in Organ Transplantation 2010;15:310-5. [DOI: 10.1097/mot.0b013e32833991f8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
133 Shehu AI, Ma X, Venkataramanan R. Mechanisms of Drug-Induced Hepatotoxicity. Clin Liver Dis. 2017;21:35-54. [PMID: 27842774 DOI: 10.1016/j.cld.2016.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
134 Kramer DJ. Invited commentary: septic shock in acute liver failure. J Crit Care 2008;23:473-4. [PMID: 19056009 DOI: 10.1016/j.jcrc.2008.08.014] [Reference Citation Analysis]
135 Polson J, Wians FH Jr, Orsulak P, Fuller D, Murray NG, Koff JM, Khan AI, Balko JA, Hynan LS, Lee WM; Acute Liver Failure Study Group. False positive acetaminophen concentrations in patients with liver injury. Clin Chim Acta 2008;391:24-30. [PMID: 18279672 DOI: 10.1016/j.cca.2008.01.018] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
136 Gopi M, Seshadri MS. Biphasic Effect of Rifampicin on Bilirubin- A Case Report. J Clin Diagn Res 2016;10:OD14-5. [PMID: 27190870 DOI: 10.7860/JCDR/2016/18040.7614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
137 Giordano C, Rivas J, Zervos X. An Update on Treatment of Drug-Induced Liver Injury. J Clin Transl Hepatol 2014;2:74-9. [PMID: 26356645 DOI: 10.14218/JCTH.2014.00005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
138 Betten DP, Vohra RB, Cook MD, Matteucci MJ, Clark RF. Antidote Use in the Critically Ill Poisoned Patient. J Intensive Care Med 2006;21:255-77. [DOI: 10.1177/0885066606290386] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 6.6] [Reference Citation Analysis]
139 Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care. 2006;4:179-189. [PMID: 16627910 DOI: 10.1385/NCC:4:2:179] [Cited by in Crossref: 60] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
140 Slavin D, Schlichting C, Freston J. Rating the severity of the medical consequences of drug-induced liver injury. Regulatory Toxicology and Pharmacology 2005;43:134-40. [DOI: 10.1016/j.yrtph.2005.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
141 Muñoz-Martínez SG, Díaz-Hernández HA, Suárez-Flores D, Sánchez-Ávila JF, Gamboa-Domínguez A, García-Juárez I, Torre A. Atypical manifestations of hepatitis A virus infection. Rev Gastroenterol Mex (Engl Ed) 2018;83:134-43. [PMID: 29685743 DOI: 10.1016/j.rgmx.2017.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
142 Connor BA, Jacobs RJ, Meyerhoff AS. Hepatitis B risks and immunization coverage among American travelers. J Travel Med 2006;13:273-80. [PMID: 16987126 DOI: 10.1111/j.1708-8305.2006.00055.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
143 Korver S, Bowen J, Pearson K, Gonzalez RJ, French N, Park K, Jenkins R, Goldring C. The application of cytokeratin-18 as a biomarker for drug-induced liver injury. Arch Toxicol 2021. [PMID: 34322741 DOI: 10.1007/s00204-021-03121-0] [Reference Citation Analysis]
144 Sasbón JS, Buamscha D, Gianivelli S, Imventarza O, Devictor D, Moreiro R, Cambaceres C, Salip G, Ciocca M, Cuarterolo M, Vladimirsky S, Otegui L, Castro R, Brajterman L, Soto S, González J, Munné MS. Clinical implications of hepatitis A virus ribonucleic acid detection and genotyping in acute liver failure in children in Argentina. Pediatr Crit Care Med 2010;11:385-9. [PMID: 20101195 DOI: 10.1097/PCC.0b013e3181ceadca] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
145 Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92:761-794, viii. [PMID: 18570942 DOI: 10.1016/j.mcna.2008.03.005] [Cited by in Crossref: 136] [Cited by in F6Publishing: 107] [Article Influence: 10.5] [Reference Citation Analysis]
146 Lutfi R, Abulebda K, Nitu ME, Molleston JP, Bozic MA, Subbarao G. Intensive Care Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2017;64:660-670. [PMID: 27741059 DOI: 10.1097/mpg.0000000000001441] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
147 Mina T, Amini Bavil Olyaee S, Tacke F, Maes P, Van Ranst M, Pourkarim MR. Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development. Hepat Mon. 2015;15:e29477. [PMID: 26288637 DOI: 10.5812/hepatmon.29477v2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
148 Novack V, Jotkowitz AB, Delgado J, Shleyfer E, Barski L, Porath A. Deliberate self-poisoning with acetaminophen: A comparison with other medications. European Journal of Internal Medicine 2005;16:585-9. [DOI: 10.1016/j.ejim.2005.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
149 Dastis SN, Rahier J, Lerut J, Geubel AP. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound: . European Journal of Gastroenterology & Hepatology 2007;19:919-22. [DOI: 10.1097/meg.0b013e3282eeb4cc] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
150 Amiri F, Molaei S, Bahadori M, Nasiri F, Deyhim MR, Jalili MA, Nourani MR, Habibi Roudkenar M. Autophagy-Modulated Human Bone Marrow-Derived Mesenchymal Stem Cells Accelerate Liver Restoration in Mouse Models of Acute Liver Failure. Iran Biomed J 2016;20:135-44. [PMID: 26899739 DOI: 10.7508/ibj.2016.03.002] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
151 Clay AS, Hainline BE. Hyperammonemia in the ICU. Chest. 2007;132:1368-1378. [PMID: 17934124 DOI: 10.1378/chest.06-2940] [Cited by in Crossref: 115] [Cited by in F6Publishing: 81] [Article Influence: 8.2] [Reference Citation Analysis]
152 Detry O, De Roover A, Coimbra C, Delwaide J, Hans MF, Delbouille MH, Monard J, Joris J, Damas P, Belaïche J, Meurisse M, Honoré P. Cadaveric liver transplantation for non-acetaminophen fulminant hepatic failure: a 20-year experience. World J Gastroenterol 2007;13:1427-30. [PMID: 17457975 DOI: 10.3748/wjg.v13.i9.1427] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
153 Poulsen KL, Olivero-Verbel J, Beggs KM, Ganey PE, Roth RA. Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response. J Pharmacol Exp Ther 2014;350:164-70. [PMID: 24817034 DOI: 10.1124/jpet.114.214189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
154 Kandiah PA, Olson JC, Subramanian RM. Emerging strategies for the treatment of patients with acute hepatic failure. Curr Opin Crit Care 2016;22:142-51. [PMID: 26849251 DOI: 10.1097/MCC.0000000000000291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
155 Hwang DB, Won DH, Shin YS, Kim SY, Kang BC, Lim KM, Che JH, Nam KT, Yun JW. Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility. Free Radic Biol Med 2020;148:128-39. [PMID: 31911150 DOI: 10.1016/j.freeradbiomed.2020.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
156 Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int. 2011;108:714-720. [PMID: 22114640 DOI: 10.3238/arztebl.2011.0714.Epub] [Reference Citation Analysis]
157 Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36:415-422. [PMID: 31421978 DOI: 10.1053/j.semdp.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
158 Chen L, Wang P, Manautou JE, Zhong XB. Knockdown of Long Noncoding RNAs Hepatocyte Nuclear Factor 1α Antisense RNA 1 and Hepatocyte Nuclear Factor 4α Antisense RNA 1 Alters Susceptibility of Acetaminophen-Induced Cytotoxicity in HepaRG Cells. Mol Pharmacol 2020;97:278-86. [PMID: 32029527 DOI: 10.1124/mol.119.118778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
159 Miyake Y, Iwasaki Y, Makino Y, Kobashi H, Takaguchi K, Ando M, Sakaguchi K, Shiratori Y. Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. J Gastroenterol Hepatol 2007;22:855-61. [PMID: 17565642 DOI: 10.1111/j.1440-1746.2007.04874.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
160 Steadman RH, Van Rensburg A, Kramer DJ. Transplantation for acute liver failure: perioperative management: . Current Opinion in Organ Transplantation 2010;15:368-73. [DOI: 10.1097/mot.0b013e32833982dd] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
161 Lee B, Park J, Ha TKQ, Pham HTT, An J, Noh J, Lee C, Oh W. Constituents of the Edible Leaves of Melicope pteleifolia with Potential Analgesic Activity. J Nat Prod 2019;82:2201-10. [DOI: 10.1021/acs.jnatprod.9b00224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
162 Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065-2076. [PMID: 20949552 DOI: 10.1002/hep.23937] [Cited by in Crossref: 440] [Cited by in F6Publishing: 342] [Article Influence: 40.0] [Reference Citation Analysis]
163 Shah J, Lingiah V, Pyrsopoulos N, Galan M. Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect. Gastroenterology Res 2019;12:263-6. [PMID: 31636777 DOI: 10.14740/gr1212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
164 Akamatsu N, Sugawara Y, Kokudo N. Acute liver failure and liver transplantation. Intractable Rare Dis Res 2013;2:77-87. [PMID: 25343108 DOI: 10.5582/irdr.2013.v2.3.77] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
165 Wong VW, Chan HL. Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease. J Gastroenterol Hepatol. 2009;24:1179-1186. [PMID: 19682192 DOI: 10.1111/j.1440-1746.2009.05924.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
166 DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 411] [Article Influence: 49.9] [Reference Citation Analysis]
167 Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA; DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology 2014;147:96-108.e4. [PMID: 24681128 DOI: 10.1053/j.gastro.2014.03.045] [Cited by in Crossref: 128] [Cited by in F6Publishing: 102] [Article Influence: 18.3] [Reference Citation Analysis]
168 da Rocha BA, Ritter AMV, Ames FQ, Gonçalves OH, Leimann FV, Bracht L, Natali MRM, Cuman RKN, Bersani-amado CA. Acetaminophen-induced hepatotoxicity: Preventive effect of trans anethole. Biomedicine & Pharmacotherapy 2017;86:213-20. [DOI: 10.1016/j.biopha.2016.12.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
169 Kuna L, Bozic I, Kizivat T, Bojanic K, Mrso M, Kralj E, Smolic R, Wu GY, Smolic M. Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives. Curr Drug Metab 2018;19:830-8. [PMID: 29788883 DOI: 10.2174/1389200219666180523095355] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 11.7] [Reference Citation Analysis]
170 Poddar B, Saigal S, Kumar A, Singh RK, Azim A, Gurjar M, Baronia A. Factors associated with outcome in acute liver failure in an intensive care unit. Indian J Gastroenterol 2013;32:172-8. [PMID: 23054946 DOI: 10.1007/s12664-012-0252-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
171 Chou JW, Bushel PR. Discernment of possible mechanisms of hepatotoxicity via biological processes over-represented by co-expressed genes. BMC Genomics 2009;10:272. [PMID: 19538742 DOI: 10.1186/1471-2164-10-272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
172 Paridaens A, Raevens S, Colle I, Bogaerts E, Vandewynckel Y, Verhelst X, Hoorens A, Grunsven LA, Van Vlierberghe H, Geerts A, Devisscher L. Combination of tauroursodeoxycholic acid and N‐acetylcysteine exceeds standard treatment for acetaminophen intoxication. Liver Int 2017;37:748-56. [DOI: 10.1111/liv.13261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
173 Paterson WG, Depew WT, Paré P, Petrunia D, Switzer C, Veldhuyzen van Zanten SJ, Daniels S; Canadian Association of Gastroenterology Wait Time Consensus Group. Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol 2006;20:411-23. [PMID: 16779459 DOI: 10.1155/2006/343686] [Cited by in Crossref: 61] [Cited by in F6Publishing: 74] [Article Influence: 4.1] [Reference Citation Analysis]
174 Frontera JA. Management of hepatic encephalopathy. Curr Treat Options Neurol. 2014;16:297. [PMID: 24807164 DOI: 10.1007/s11940-014-0297-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
175 Holt EW, Demartini S, Davern TJ. Acute Liver Failure Due to Acetaminophen Poisoning in Patients With Prior Weight Loss Surgery: A Case Series. Journal of Clinical Gastroenterology 2015;49:790-3. [DOI: 10.1097/mcg.0000000000000278] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
176 Ichai P, Samuel D. Epidemiology of liver failure. Clinics and Research in Hepatology and Gastroenterology 2011;35:610-7. [DOI: 10.1016/j.clinre.2011.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
177 Becker MW, Lunardelli MJM, Tovo CV, Blatt CR. Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAM. Ann Hepatol. 2019;18:742-750. [PMID: 31130470 DOI: 10.1016/j.aohep.2019.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
178 Lee WM, Senior JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol. 2005;33:155-164. [PMID: 15805067 DOI: 10.1080/01926230590522356] [Cited by in Crossref: 131] [Cited by in F6Publishing: 109] [Article Influence: 8.2] [Reference Citation Analysis]
179 Zhao R, Liu X, Yang X, Jin B, Shao C, Kang W, Tang R. Nanomaterial-Based Organelles Protect Normal Cells against Chemotherapy-Induced Cytotoxicity. Adv Mater 2018;30:1801304. [DOI: 10.1002/adma.201801304] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
180 Li YC, Shen JD, Lu SF, Zhu LL, Wang BY, Bai M, Xu EP. Transcriptomic analysis reveals the mechanism of sulfasalazine-induced liver injury in mice. Toxicol Lett 2020;321:12-20. [PMID: 31830553 DOI: 10.1016/j.toxlet.2019.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
181 Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935-952. [PMID: 17021358 DOI: 10.1164/rccm.200510-1666st] [Cited by in Crossref: 597] [Cited by in F6Publishing: 204] [Article Influence: 39.8] [Reference Citation Analysis]
182 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 7.6] [Reference Citation Analysis]
183 Mondaca SP, Liu D, Flynn JR, Badson S, Hamaway S, Gounder MM, Khalil DN, Drilon AE, Li BT, Jhaveri KL, Schram AM, Kargus KE, Kasler MK, Blauvelt NM, Segal NH, Capanu M, Callahan MK, Hyman DM, Gambarin-Gelwan M, Harding JJ. Clinical implications of drug-induced liver injury in early-phase oncology clinical trials. Cancer 2020;126:4967-74. [PMID: 32809222 DOI: 10.1002/cncr.33153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Huo M. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: Are they really better? Thromb Haemost 2017;106:45-57. [DOI: 10.1160/th10-10-0653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
185 Licata A, Maida M, Cabibi D, Butera G, Macaluso FS, Alessi N, Caruso C, Craxì A, Almasio PL. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study. Dig Liver Dis 2014;46:1116-20. [PMID: 25224696 DOI: 10.1016/j.dld.2014.08.040] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
186 Kon K, Ikejima K, Okumura K, Arai K, Aoyama T, Watanabe S. Diabetic KK-A y mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010;299:G329-37. [DOI: 10.1152/ajpgi.00361.2009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
187 Li J, Zhu X, Liu F, Cai P, Sanders C, Lee WM, Uetrecht J. Cytokine and autoantibody patterns in acute liver failure. J Immunotoxicol. 2010;7:157-164. [PMID: 20039781 DOI: 10.3109/15476910903501748] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
188 Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010;1184:173-87. [PMID: 20146697 DOI: 10.1111/j.1749-6632.2009.05109.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 111] [Article Influence: 16.4] [Reference Citation Analysis]
189 Lin K, Lin AN, Linn S, Hlaing PP, Vasudevan V, Reddy M. Ginseng-Related Drug-Induced Liver Injury. Case Rep Gastroenterol 2018;12:439-46. [PMID: 30186097 DOI: 10.1159/000490525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
190 Grande RG, Pérez MJ. Liver Transplantation in Acute Liver Failure: Indications and Outcome. In: Rodrigo L, editor. Liver Research and Clinical Management. InTech; 2018. [DOI: 10.5772/intechopen.72664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
191 Bhamidimarri KR, Schiff E. Drug-induced cholestasis. Clin Liver Dis. 2013;17:519-531, vii. [PMID: 24099015 DOI: 10.1016/j.cld.2013.07.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
192 Lee WM. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol. 2012;26:3-16. [PMID: 22482521 DOI: 10.1016/j.bpg.2012.01.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 8.6] [Reference Citation Analysis]
193 Le Minh K, Klemm K, Abshagen K, Eipel C, Menger MD, Vollmar B. Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am J Pathol 2007;170:1954-63. [PMID: 17525263 DOI: 10.2353/ajpath.2007.061056] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
194 Jayaraman T, Lee YY, Chan WK, Mahadeva S. Epidemiological differences of common liver conditions between Asia and the West. JGH Open. 2020;4:332-339. [PMID: 32514433 DOI: 10.1002/jgh3.12275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
195 Mennecozzi M, Landesmann B, Palosaari T, Harris G, Whelan M. Sex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro? PLoS One 2015;10:e0122786. [PMID: 25849576 DOI: 10.1371/journal.pone.0122786] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
196 Wang S, Shangguan Y, Ding C, Li P, Ji Z, Shao J, Fang H, Yang M, Shi P, Wu J, Ren J, Yang S, Yuan J, Shi Y, Li J, Li L, Xu K. Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury. J Int Med Res 2020;48:300060518811512. [PMID: 30477373 DOI: 10.1177/0300060518811512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
197 Steinebrunner N, Mogler C, Vittas S, Hoyler B, Sandig C, Stremmel W, Eisenbach C. Pharmacologic cholinesterase inhibition improves survival in acetaminophen-induced acute liver failure in the mouse. BMC Gastroenterol. 2014;14:148. [PMID: 25139304 DOI: 10.1186/1471-230x-14-148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
198 Han MK, Hyzy R. Advances in critical care management of hepatic failure and insufficiency: . Critical Care Medicine 2006;34:S225-31. [DOI: 10.1097/01.ccm.0000231882.85350.71] [Cited by in Crossref: 40] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
199 Sass DA, Shakil AO. Fulminant hepatic failure. Gastroenterol Clin North Am. 2003;32:1195-1211. [PMID: 14696303 DOI: 10.1016/S0889-8553(03)00088-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
200 Miyake Y, Sakaguchi K, Iwasaki Y, Ikeda H, Makino Y, Kobashi H, Araki Y, Ando M, Kita K, Shiratori Y. New prognostic scoring model for liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. Transplantation. 2005;80:930-936. [PMID: 16249741 DOI: 10.1097/01.tp.0000173651.39645.35] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
201 Aleksunes LM, Slitt AL, Maher JM, Augustine LM, Goedken MJ, Chan JY, Cherrington NJ, Klaassen CD, Manautou JE. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol. 2008;226:74-83. [PMID: 17935745 DOI: 10.1016/j.taap.2007.08.022] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 8.0] [Reference Citation Analysis]
202 Li CC, Yu HF, Chang CH, Liu YT, Yao HT. Effects of lemongrass oil and citral on hepatic drug-metabolizing enzymes, oxidative stress, and acetaminophen toxicity in rats. J Food Drug Anal 2018;26:432-8. [PMID: 29389585 DOI: 10.1016/j.jfda.2017.01.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
203 Shribman S, Warner TT, Dooley JS. Clinical presentations of Wilson disease. Ann Transl Med. 2019;7:S60. [PMID: 31179297 DOI: 10.21037/atm.2019.04.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
204 Yang R, Bai Q, Zhang J, Sheng Y, Ji L. The altered liver microRNA profile in hepatotoxicity induced by rhizome Dioscorea bulbifera in mice. Hum Exp Toxicol 2017;36:823-32. [PMID: 27609015 DOI: 10.1177/0960327116666651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
205 Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother. 2004;38:498-500. [PMID: 14742832 DOI: 10.1345/aph.1d209] [Cited by in Crossref: 45] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
206 Wong A, Sivilotti MLA, Graudins A. Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose. Clinical Toxicology 2017;55:346-51. [DOI: 10.1080/15563650.2017.1290253] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
207 Choudhary NS, Saigal S, Saraf N, Rastogi A, Goja S, Bhangui P, Thiagrajan S, Gautam D, Govil D, Vohra V, Soin AS. Outcome of Living Donor Liver Transplantation for Wilson's Disease in Adults: A Single Center Experience. J Clin Exp Hepatol 2018;8:132-5. [PMID: 29892175 DOI: 10.1016/j.jceh.2017.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
208 Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients. Hepatol Int 2016;10:838-46. [DOI: 10.1007/s12072-016-9735-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
209 Wang GQ, Deng YQ, Hou FQ. Overview of drug-induced liver injury in China. Clin Liver Dis (Hoboken) 2014;4:26-9. [PMID: 30992915 DOI: 10.1002/cld.386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
210 Stuart WD, Kulkarni RM, Gray JK, Vasiliauskas J, Leonis MA, Waltz SE. Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology. 2011;53:1618-1628. [PMID: 21520175 DOI: 10.1002/hep.24239] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
211 Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP, McMahon M, Hayes JD, Itoh K, Yamamoto M, Park BK. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. Hepatology. 2004;39:1267-1276. [PMID: 15122755 DOI: 10.1002/hep.20183] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 8.6] [Reference Citation Analysis]
212 Goldring C, Weaver R, Kramer B, Klingmueller U, Oppelt A, Van der Water B, Commandeur J, Guillouzo A, Naisbitt D, French N, Kitteringham N, Pridgeon C, Knolle P, Sidaway J, Sison-young R, Kamalian L, Mercer A, Faulkner L, Pieters R, Ingelman-sundberg M, Kevin Park B. Drug-Induced Liver Injury: Mechanism-Informed Prediction in Drug Development. Comprehensive Medicinal Chemistry III. Elsevier; 2017. pp. 217-38. [DOI: 10.1016/b978-0-12-409547-2.12384-4] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
213 Lee WM. Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology. 2007;46:966-970. [PMID: 17894320 DOI: 10.1002/hep.21926] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
214 Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero-Gómez M. Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology. 2014;147:109-118.e5. [PMID: 24704526 DOI: 10.1053/j.gastro.2014.03.050] [Cited by in Crossref: 161] [Cited by in F6Publishing: 135] [Article Influence: 23.0] [Reference Citation Analysis]
215 Mcpheeters CM, Vanarsdale VM, Weant KA. N-Acetylcysteine Use in Non-Acetaminophen-Induced Acute Liver Failure. Advanced Emergency Nursing Journal 2016;38:183-9. [DOI: 10.1097/tme.0000000000000116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
216 Copple IM. The Keap1-Nrf2 cell defense pathway--a promising therapeutic target? Adv Pharmacol. 2012;63:43-79. [PMID: 22776639 DOI: 10.1016/b978-0-12-398339-8.00002-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 61] [Article Influence: 11.8] [Reference Citation Analysis]
217 Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2014;33:928-939. [PMID: 24299907 DOI: 10.1177/0960327113512860] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
218 Ryan A, Nevitt SJ, Tuohy O, Cook P. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Syst Rev 2019;2019. [PMID: 31743430 DOI: 10.1002/14651858.CD012267.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
219 Dalal KK, Holdbrook T, Peikin SR. Ayurvedic drug induced liver injury. World J Hepatol 2017;9:1205-9. [PMID: 29152040 DOI: 10.4254/wjh.v9.i31.1205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
220 Treeprasertsuk S, Huntrakul J, Ridtitid W, Kullavanijaya P, Björnsson ES. The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents. Aliment Pharmacol Ther 2010;31:1200-7. [PMID: 20222907 DOI: 10.1111/j.1365-2036.2010.04292.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
221 Sun L, Fan X, Zhang L, Shi G, Aili M, Lu X, Jiang T, Zhang Y. Bone mesenchymal stem cell transplantation via four routes for the treatment of acute liver failure in rats. Int J Mol Med 2014;34:987-96. [PMID: 25110277 DOI: 10.3892/ijmm.2014.1890] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
222 Palomo L, Mleczko JE, Azkargorta M, Conde-Vancells J, González E, Elortza F, Royo F, Falcon-Perez JM. Abundance of Cytochromes in Hepatic Extracellular Vesicles Is Altered by Drugs Related With Drug-Induced Liver Injury. Hepatol Commun 2018;2:1064-79. [PMID: 30202821 DOI: 10.1002/hep4.1210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
223 Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol 2013;7:701-12. [PMID: 24134153 DOI: 10.1586/17474124.2013.837264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
224 Lauschke VM. Toxicogenomics of drug induced liver injury - from mechanistic understanding to early prediction. Drug Metab Rev 2021;53:245-52. [PMID: 33683927 DOI: 10.1080/03602532.2021.1894571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
225 Abdelmegeed MA, Moon KH, Chen C, Gonzalez FJ, Song BJ. Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol 2010;79:57-66. [PMID: 19660437 DOI: 10.1016/j.bcp.2009.07.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
226 Khan SA, Shah N, Williams R, Jalan R. Acute liver failure: a review. Clin Liver Dis 2006;10:239-58, vii-viii. [PMID: 16971260 DOI: 10.1016/j.cld.2006.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
227 Lu BR, Gralla J, Liu E, Dobyns EL, Narkewicz MR, Sokol RJ. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol. 2008;6:1140-1145. [PMID: 18928939 DOI: 10.1016/j.cgh.2008.05.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
228 Gahr M, Zeiss R, Lang D, Connemann BJ, Hiemke C, Schönfeldt-lecuona C. Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms. The Journal of Clinical Pharmacology 2016;56:769-78. [DOI: 10.1002/jcph.662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
229 McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King's College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis. Clin Gastroenterol Hepatol 2016;14:516-525.e5; quiz e43-e45. [PMID: 26499930 DOI: 10.1016/j.cgh.2015.10.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
230 Kulkarni S, Perez C, Pichardo C, Castillo L, Gagnon M, Beck-sague C, Gereige R, Hernandez E. Use of Pediatric Health Information System database to study the trends in the incidence, management, etiology, and outcomes due to pediatric acute liver failure in the United States from 2008 to 2013. Pediatr Transplantation 2015;19:888-95. [DOI: 10.1111/petr.12596] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
231 Fernandes CT, Iqbal U, Tighe SP, Ahmed A. Kratom-Induced Cholestatic Liver Injury and Its Conservative Management. J Investig Med High Impact Case Rep. 2019;7:2324709619836138. [PMID: 30920318 DOI: 10.1177/2324709619836138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
232 Lee WM. Liver: determining prognosis in acute liver failure. Nat Rev Gastroenterol Hepatol 2012;9:192-4. [PMID: 22392292 DOI: 10.1038/nrgastro.2012.34] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
233 Wang Y, Xie X, Liu H, Liu H, Jiang H. LR12 Promotes Liver Repair by Improving the Resolution of Inflammation and Liver Regeneration in Mice with Thioacetamide- (TAA-) Induced Acute Liver Failure. Mediators Inflamm 2021;2021:2327721. [PMID: 34135689 DOI: 10.1155/2021/2327721] [Reference Citation Analysis]
234 Novak D, Lewis JH. Drug-induced liver disease: . Current Opinion in Gastroenterology 2003;19:203-15. [DOI: 10.1097/00001574-200305000-00004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
235 Rajekar H, Wai CT, Majeed TA, Lee KH, Wong SY, Leong SO, Singh R, Tay KH, Soosaynathan C, Tan KC. Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation. Transplant Proc. 2008;40:2492-2493. [PMID: 18929776 DOI: 10.1016/j.transproceed.2008.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
236 Dabos KJ, Newsome PN, Parkinson JA, Davidson JS, Sadler IH, Plevris JN, Hayes PC. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation. 2005;80:1712-1717. [PMID: 16378066 DOI: 10.1097/01.tp.0000187879.51616.e0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
237 Kalgutkar AS. Designing around Structural Alerts in Drug Discovery. J Med Chem 2020;63:6276-302. [PMID: 31497963 DOI: 10.1021/acs.jmedchem.9b00917] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
238 Singhal A, Neuberger J. Acute liver failure: Bridging to transplant or recovery– are we there yet? Journal of Hepatology 2007;46:557-64. [DOI: 10.1016/j.jhep.2007.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
239 Knudsen TT, Thorsen S, Jensen SA, Dalhoff K, Schmidt LE, Becker U, Bendtsen F. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 2005;54:515-21. [PMID: 15753537 DOI: 10.1136/gut.2004.043505] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
240 Hwang S, Lee SG, Park JI, Song GW, Ryu JH, Jung DH, Hwang GS, Jeong SM, Song JG, Hong SK. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91-97. [PMID: 19925461 DOI: 10.1111/j.1399-0012.2009.01148.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
241 Urban TJ, Goldstein DB, Watkins PB. Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here? Pharmacogenomics 2012;13:735-8. [PMID: 22594502 DOI: 10.2217/pgs.12.45] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
242 Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat Rev Drug Discov 2020;19:131-48. [DOI: 10.1038/s41573-019-0048-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 24.0] [Reference Citation Analysis]
243 Chen M, Borlak J, Tong W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology. 2013;58:388-396. [PMID: 23258593 DOI: 10.1002/hep.26208] [Cited by in Crossref: 207] [Cited by in F6Publishing: 166] [Article Influence: 25.9] [Reference Citation Analysis]
244 Kaplowitz N. Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 3-14. [DOI: 10.1016/b978-0-12-387817-5.00001-7] [Cited by in Crossref: 26] [Article Influence: 3.3] [Reference Citation Analysis]
245 Fisher JE, McKenzie TJ, Lillegard JB, Yu Y, Juskewitch JE, Nedredal GI, Brunn GJ, Yi ES, Malhi H, Smyrk TC, Nyberg SL. Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure. J Surg Res 2013;180:147-55. [PMID: 23260383 DOI: 10.1016/j.jss.2012.11.051] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
246 Lin H, Zhang Q, Li X, Wu Y, Liu Y, Hu Y. Identification of key candidate genes and pathways in hepatitis B virus-associated acute liver failure by bioinformatical analysis. Medicine (Baltimore). 2018;97:e9687. [PMID: 29384847 DOI: 10.1097/md.0000000000009687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
247 Bernal W, Cross TJ, Auzinger G, Sizer E, Heneghan MA, Bowles M, Muiesan P, Rela M, Heaton N, Wendon J, O'Grady JG. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol. 2009;50:306-313. [PMID: 19070386 DOI: 10.1016/j.jhep.2008.09.012] [Cited by in Crossref: 116] [Cited by in F6Publishing: 85] [Article Influence: 8.9] [Reference Citation Analysis]
248 Nalpas B, Ichaï P, Jamot L, Carbonell N, Rudler M, Mathurin P, Durand F, Gerken G, Manns M, Trautwein C, Larrey D, Radenne S, Duvoux C, Leroy V, Bernuau J, Faivre J, Moniaux N, Bréchot C, Amouyal G, Amouyal P, Samuel D. A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases. PLoS One 2016;11:e0150733. [PMID: 26983031 DOI: 10.1371/journal.pone.0150733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
249 Myers DB, Highton TC, Rayns DG. Ruthenium red-positive filaments interconnecting collagen fibrils. J Ultrastruct Res 1973;42:87-92. [PMID: 4119259 DOI: 10.1016/s0022-5320(73)80008-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
250 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
251 Hoshino K, Nakamura Y, Nakano T, Watanabe A, Sheng H, Tachibana K, Ishikura H. Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure. Sci Rep 2020;10:1742. [PMID: 32015385 DOI: 10.1038/s41598-020-58624-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Al Humayed S, Al-Ani B, El Karib AO, Shatoor AS, Eid RA, Aziz S, Wani JI, Haidara MA. Suppression of acetaminophen-induced hepatocyte ultrastructural alterations in rats using a combination of resveratrol and quercetin. Ultrastruct Pathol 2019;43:162-9. [PMID: 31631752 DOI: 10.1080/01913123.2019.1680585] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
253 Maiuri AR, Wassink B, Turkus JD, Breier AB, Lansdell T, Kaur G, Hession SL, Ganey PE, Roth RA. Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study. J Pharmacol Exp Ther 2017;362:459-73. [PMID: 28687704 DOI: 10.1124/jpet.117.242354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
254 Molinari M, Watt KD, Kruszyna T, Nelson R, Walsh M, Huang WY, Nashan B, Peltekian K. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl. 2006;12:1892-1895. [PMID: 17133573 DOI: 10.1002/lt.21021] [Cited by in Crossref: 110] [Cited by in F6Publishing: 92] [Article Influence: 7.9] [Reference Citation Analysis]
255 Faraj W, Dar F, Bartlett A, Melendez HV, Marangoni G, Mukherji D, Vergani GM, Dhawan A, Heaton N, Rela M. Auxiliary liver transplantation for acute liver failure in children. Ann Surg. 2010;251:351-356. [PMID: 20054274 DOI: 10.1097/sla.0b013e3181bdfef6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
256 Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-Paracetamol Prescription Patterns and Liver Dysfunction: A Retrospective Cohort Study in a Population Served by a US Health Benefits Organization. Drug Safety 2011;34:1079-88. [DOI: 10.2165/11593100-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
257 Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology. 2009;50:538-545. [PMID: 19575457 DOI: 10.1002/hep.23042] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 8.8] [Reference Citation Analysis]
258 Gupta N, Patel C, Panda M. Hepatitis following famotidine: a case report. Cases J 2009;2:89. [PMID: 19173722 DOI: 10.1186/1757-1626-2-89] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
259 Whitehouse T, Wendon J. Acute liver failure. Best Pract Res Clin Gastroenterol. 2013;27:757-769. [PMID: 24160932 DOI: 10.1016/j.bpg.2013.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
260 Lee FY, Wong HS, Chan HK, Mohamed Ali N, Abu Hassan MR, Omar H, Abdul Mutalib NA. Hepatic adverse drug reactions in Malaysia: An 18-year review of the national centralized reporting system.Pharmacoepidemiol Drug Saf. 2020;29:1669-1679. [PMID: 33064335 DOI: 10.1002/pds.5153] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
261 Chakraborty M, Fullerton AM, Semple K, Chea LS, Proctor WR, Bourdi M, Kleiner DE, Zeng X, Ryan PM, Dagur PK, Berkson JD, Reilly TP, Pohl LR. Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment. Hepatology 2015;62:546-57. [PMID: 25712247 DOI: 10.1002/hep.27764] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
262 Li T, Tong W, Roberts R, Liu Z, Thakkar S. Deep Learning on High-Throughput Transcriptomics to Predict Drug-Induced Liver Injury. Front Bioeng Biotechnol 2020;8:562677. [PMID: 33330410 DOI: 10.3389/fbioe.2020.562677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
263 Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei I, Encke J, Schmidt H, Vogel W. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006;13:256-263. [PMID: 16611192 DOI: 10.1111/j.1365-2893.2005.00695.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 101] [Article Influence: 9.5] [Reference Citation Analysis]
264 Park K, Antoine DJ, Pirmohamed M. Treatment of paracetamol overdose: room for improvement? Lancet 2014;383:672-4. [PMID: 24290402 DOI: 10.1016/S0140-6736(13)62303-X] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Hornsby LB, Whitley HP, Kelly Hester E, Melissa T, Donaldson A. Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity. Journal of the American Pharmacists Association 2010;50:485-9. [DOI: 10.1331/japha.2010.08175] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
266 Hong L, Li Y, Liu Q, Chen Q, Chen L, Zhou D. The Hippo Signaling Pathway in Regenerative Medicine. Methods Mol Biol 2019;1893:353-70. [PMID: 30565146 DOI: 10.1007/978-1-4939-8910-2_26] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
267 Salam GD, Kumar A, Kar P, Aggarwal S, Husain A, Sharma S. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol Res 2013;43:826-35. [PMID: 23279190 DOI: 10.1111/hepr.12028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
268 Hadem J, Stiefel P, Bahr MJ, Tillmann HL, Rifai K, Klempnauer J, Wedemeyer H, Manns MP, Schneider AS. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6:339-345. [PMID: 18328438 DOI: 10.1016/j.cgh.2007.12.039] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
269 Ou P, Chen Y, Li B, Zhang M, Liu X, Li F, Li Y, Chen C, Mao Y, Chen J. Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital. Springerplus. 2015;4:802. [PMID: 26702391 DOI: 10.1186/s40064-015-1600-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
270 Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007;9:66-73. [DOI: 10.1007/s11894-008-0023-x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
271 Ichai P, Samuel D. Management of Fulminant Hepatitis B. Curr Infect Dis Rep 2019;21:25. [PMID: 31165271 DOI: 10.1007/s11908-019-0682-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
272 Yang R, Yang F, Huang Z, Jin Y, Sheng Y, Ji L. Serum microRNA-122-3p, microRNA-194-5p and microRNA-5099 are potential toxicological biomarkers for the hepatotoxicity induced by Airpotato yam. Toxicology Letters 2017;280:125-32. [DOI: 10.1016/j.toxlet.2017.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
273 Eapen J, Ayoola R, Subramanian RM. 'The efficacy of extracorporeal liver support with molecular adsorbent recirculating system in severe drug-induced liver injury'. Oxf Med Case Reports 2018;2018:omx077. [PMID: 29308212 DOI: 10.1093/omcr/omx077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
274 Uetrecht J. Evaluation of Which Reactive Metabolite, If Any, Is Responsible for a Specific Idiosyncratic Reaction. Drug Metabolism Reviews 2008;38:745-53. [DOI: 10.1080/03602530600959615] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
275 Stevens RD, Nyquist PA. The systemic implications of aneurysmal subarachnoid hemorrhage. Journal of the Neurological Sciences 2007;261:143-56. [DOI: 10.1016/j.jns.2007.04.047] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
276 Myers RP, Leung Y, Shaheen AA, Li B. Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res 2007;7:159. [PMID: 17910762 DOI: 10.1186/1472-6963-7-159] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
277 Bunchorntavakul C, Reddy KR. Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and Acute Liver Failure. Clinics in Liver Disease 2018;22:325-46. [DOI: 10.1016/j.cld.2018.01.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 18.3] [Reference Citation Analysis]
278 Baliga P, Alvarez S, Lindblad A, Zeng L. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl. 2004;10:1364-1371. [PMID: 15497159 DOI: 10.1002/lt.20252] [Cited by in Crossref: 74] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
279 Shapiro MA, Lewis JH. Causality Assessment of Drug-Induced Hepatotoxicity: Promises and Pitfalls. Clinics in Liver Disease 2007;11:477-505. [DOI: 10.1016/j.cld.2007.06.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
280 Cui Y, Paules RS. Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 2010;11:573-85. [PMID: 20350139 DOI: 10.2217/pgs.10.37] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
281 Giri S, Nieber K, Bader A. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opinion on Drug Metabolism & Toxicology 2010;6:895-917. [DOI: 10.1517/17425251003792521] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
282 Daly AK. Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury? Pharm Res 2017;34:1564-9. [PMID: 28028769 DOI: 10.1007/s11095-016-2091-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
283 Vliegenthart ADB, Berends C, Potter CMJ, Kersaudy-Kerhoas M, Dear JW. MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol 2017;83:2027-33. [PMID: 28257154 DOI: 10.1111/bcp.13282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
284 Guo JJ, Wigle PR, Lammers K, Vu O. Comparison of potentially hepatotoxic drugs among major US drug compendia. Research in Social and Administrative Pharmacy 2005;1:460-79. [DOI: 10.1016/j.sapharm.2005.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
285 Chang A, Krygier DS, Chatur N, Yoshida EM. Clozapine-induced fatal fulminant hepatic failure: a case report. Can J Gastroenterol. 2009;23:376-378. [PMID: 19440569 DOI: 10.1007/978-3-540-85705-1_38] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
286 Kim JD, Choi JY, Park C, Song MJ, Jang JW, Bae SH, Yoon SK, Lee YS, You YK, Kim DG. Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes. Korean J Hepatol 2010;16:19. [DOI: 10.3350/kjhep.2010.16.1.19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
287 Davern TJ. Indeterminate acute liver failure: A riddle wrapped in a mystery inside an enigma. Hepatology 2006;44:765-8. [DOI: 10.1002/hep.21305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
288 Hughes TB, Swamidass SJ. Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism. Chem Res Toxicol 2017;30:642-56. [PMID: 28099803 DOI: 10.1021/acs.chemrestox.6b00385] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
289 Williams DP, Shipley R, Ellis MJ, Webb S, Ward J, Gardner I, Creton S. Novel in vitro and mathematical models for the prediction of chemical toxicity. Toxicol Res (Camb) 2013;2:40-59. [PMID: 26966512 DOI: 10.1039/c2tx20031g] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
290 Bansod S, Saifi MA, Godugu C. Molecular updates on berberine in liver diseases: Bench to bedside. Phytother Res 2021. [PMID: 34056769 DOI: 10.1002/ptr.7181] [Reference Citation Analysis]
291 Kubo K, Kimura N, Mabe K, Matsuda S, Tsuda M, Kato M. Acute liver failure associated with diffuse large B-cell lymphoma: an autopsy case report. Clin J Gastroenterol 2020;13:1213-8. [PMID: 31919674 DOI: 10.1007/s12328-019-01091-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Devarbhavi H, Singh R, Adarsh CK, Sheth K, Kiran R, Patil M. Factors that predict mortality in children with Wilson disease associated acute liver failure and comparison of Wilson disease specific prognostic indices. J Gastroenterol Hepatol. 2014;29:380-386. [PMID: 24033813 DOI: 10.1111/jgh.12356] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
293 Khandelwal N, James LP, Sanders C, Larson AM, Lee WM; Acute Liver Failure Study Group. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011;53:567-76. [PMID: 21274877 DOI: 10.1002/hep.24060] [Cited by in Crossref: 112] [Cited by in F6Publishing: 83] [Article Influence: 11.2] [Reference Citation Analysis]
294 Mcgill MR, Cao M, Svetlov A, Sharpe MR, Williams CD, Curry SC, Farhood A, Jaeschke H, Svetlov SI. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 2014;19:222-30. [DOI: 10.3109/1354750x.2014.897757] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
295 Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, Samuel D, Simpson KJ, Yaron I, Bernardi M. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. Journal of Hepatology 2017;66:1047-81. [DOI: 10.1016/j.jhep.2016.12.003] [Cited by in Crossref: 280] [Cited by in F6Publishing: 206] [Article Influence: 70.0] [Reference Citation Analysis]
296 Kim SY, Kim BH, Dong SH, Kim HJ, Chang YW, Chang R, Kim YW. Alfuzosin-induced acute liver injury. Korean J Hepatol 2007;13:414-8. [PMID: 17898558 DOI: 10.3350/kjhep.2007.13.3.414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
297 Tracy B, Shrestha R, Stein L, Bhasin D, Pollinger H, Rubin RA. Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure. Transpl Infect Dis 2017;19. [PMID: 28273391 DOI: 10.1111/tid.12690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
298 Wang T, Papoutsi M, Wiesmann M, Decristofaro M, Keselica MC, Skuba E, Spaet R, Markovits J, Wolf A, Moulin P, Pognan F, Vancutsem P, Petryk L, Sutton J, Chibout S, Kluwe W. Investigation of Correlation Among Safety Biomarkers in Serum, Histopathological Examination, and Toxicogenomics. Int J Toxicol 2011;30:300-12. [DOI: 10.1177/1091581811401920] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
299 da Rosa EJ, da Silva MH, Carvalho NR, Bridi JC, da Rocha JB, Carbajo-Pescador S, Mauriz JL, González-Gallego J, Soares FA. Reduction of acute hepatic damage induced by acetaminophen after treatment with diphenyl diselenide in mice. Toxicol Pathol 2012;40:605-13. [PMID: 22301948 DOI: 10.1177/0192623311436179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
300 Singhal A, Vadlamudi S, Stokes K, Cassidy FP, Corn A, Shrago SS, Wright HI, Kohli V. Liver histology as predictor of outcome in patients with acute liver failure. Transpl Int. 2012;25:658-662. [PMID: 22487361 DOI: 10.1111/j.1432-2277.2012.01470.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
301 Elzagallaai AA, Rieder MJ. In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology. Br J Clin Pharmacol 2015;80:889-900. [PMID: 25199801 DOI: 10.1111/bcp.12505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
302 Kesavarapu K, Kang M, Shin JJ, Rothstein K. Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case Rep Gastrointest Med. 2017;2017:3540756. [PMID: 29204300 DOI: 10.1155/2017/3540756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
303 Ogier JM, Nayagam BA, Lockhart PJ. ASK1 inhibition: a therapeutic strategy with multi-system benefits. J Mol Med (Berl) 2020;98:335-48. [PMID: 32060587 DOI: 10.1007/s00109-020-01878-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
304 Putignano A, Figorilli F, Alabsawy E, Agarwal B, Jalan R. Long-term outcome in patients with acute liver failure. Liver Int 2018;38:2228-38. [DOI: 10.1111/liv.13914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
305 Mohsenin V. Assessment and management of cerebral edema and intracranial hypertension in acute liver failure. Journal of Critical Care 2013;28:783-91. [DOI: 10.1016/j.jcrc.2013.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
306 Smith ID, Simpson KJ, Garden OJ, Wigmore SJ. Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland. Eur J Gastroenterol Hepatol 2005;17:161-7. [PMID: 15674093 DOI: 10.1097/00042737-200502000-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
307 Akamatsu N, Sugawara Y. Acute liver failure and living donor liver transplantation. Hepatology Research 2008;38:S60-71. [DOI: 10.1111/j.1872-034x.2008.00429.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
308 Ndekwe P, Ghabril MS, Zang Y, Mann SA, Cummings OW, Lin J. Substantial hepatic necrosis is prognostic in fulminant liver failure. World J Gastroenterol. 2017;23:4303-4310. [PMID: 28694671 DOI: 10.3748/wjg.v23.i23.4303] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
309 Hernández N, Bessone F, Sánchez A, Pace MD, Brahm J, Zapata R, Chirino RA, Dávalos M, Méndez-sánchez N, Arrese M, Schinoni M, Lucena MI, Andrade RJ. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Annals of Hepatology 2014;13:231-9. [DOI: 10.1016/s1665-2681(19)30886-5] [Cited by in Crossref: 22] [Article Influence: 3.1] [Reference Citation Analysis]
310 Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89:95-106. [PMID: 24388027 DOI: 10.1016/j.mayocp.2013.09.016] [Cited by in Crossref: 208] [Cited by in F6Publishing: 168] [Article Influence: 29.7] [Reference Citation Analysis]
311 Goyal RK, Srivastava D, Lessnau K. Clopidogrel-Induced Hepatocellular Injury and Cholestatic Jaundice in an Elderly Patient: Case Report and Review of the Literature. Pharmacotherapy 2009;29:608-12. [DOI: 10.1592/phco.29.5.608] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
312 Bell CC, Lauschke VM, Vorrink SU, Palmgren H, Duffin R, Andersson TB, Ingelman-Sundberg M. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab Dispos 2017;45:419-29. [PMID: 28137721 DOI: 10.1124/dmd.116.074369] [Cited by in Crossref: 96] [Cited by in F6Publishing: 75] [Article Influence: 24.0] [Reference Citation Analysis]
313 McCarberg B, Gibofsky A. Need to develop new nonsteroidal anti-inflammatory drug formulations. Clin Ther 2012;34:1954-63. [PMID: 22939163 DOI: 10.1016/j.clinthera.2012.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
314 Zhang Y, Luo JX, Hu XY, Yang F, Zhong S, Lin W. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World J Gastroenterol 2016;22:2558-65. [PMID: 26937143 DOI: 10.3748/wjg.v22.i8.2558] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
315 Kumar R, Bhatia V. Structured approach to treat patients with acute liver failure: A hepatic emergency. Indian J Crit Care Med. 2012;16:1-7. [PMID: 22557825 DOI: 10.4103/0972-5229.94409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
316 Dargan PI, Jones AL. Management of paracetamol poisoning. Trends in Pharmacological Sciences 2003;24:154-7. [DOI: 10.1016/s0165-6147(03)00053-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
317 Andrade RJ, Camargo R, Lucena MI, González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf. 2004;3:329-344. [PMID: 15268650 DOI: 10.1517/14740338.3.4.329] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
318 Gandhi D, Ahuja K, Quade A, Batts KP, Patel L. Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report. World J Hepatol 2020;12:863-9. [PMID: 33200023 DOI: 10.4254/wjh.v12.i10.863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
319 Wong NZ, Reddy KR, Bittermann T. Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort. Liver Transpl 2021. [PMID: 34081838 DOI: 10.1002/lt.26187] [Reference Citation Analysis]
320 Kasper H, Drebber U, Hirsch I, Dienes HP. Morphologische Veränderungen der medikamenteninduzierten Leberschädigung. Pathologe 2006;27:175-81. [DOI: 10.1007/s00292-006-0826-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
321 Kantola T, Ilmakunnas M, Koivusalo A, Isoniemi H. Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland. Scand J Surg 2011;100:8-13. [DOI: 10.1177/145749691110000103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
322 He Y, Xia Z, Yu D, Wang J, Jin L, Huang D, Ye X, Li X, Zhang B. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice. Int Immunopharmacol 2019;68:171-8. [PMID: 30641432 DOI: 10.1016/j.intimp.2018.12.059] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
323 Tran T, Lee WM. DILI: New Insights into Diagnosis and Management. Curr Hepat Rep 2013;12:53-8. [PMID: 23730228 DOI: 10.1007/s11901-012-0159-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
324 Lim Y. Acute liver failure in Korea: etiology, prognosis and treatment. Korean J Hepatol 2010;16:5. [DOI: 10.3350/kjhep.2010.16.1.5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
325 Oda S, Shirai Y, Akai S, Nakajima A, Tsuneyama K, Yokoi T. Toxicological role of an acyl glucuronide metabolite in diclofenac-induced acute liver injury in mice. J Appl Toxicol 2017;37:545-53. [PMID: 27671914 DOI: 10.1002/jat.3388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
326 Isabel Lucena M, García-cortés M, Cueto R, Lopez-duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141-58. [DOI: 10.1111/j.1472-8206.2008.00566.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
327 Kowalec K, Kingwell E, Yoshida EM, Marrie RA, Kremenchutzky M, Campbell TL, Wadelius M, Carleton B, Tremlett H. Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients. Expert Opinion on Drug Safety 2014;13:1305-17. [DOI: 10.1517/14740338.2014.947958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
328 Larson AM. Diagnosis and management of acute liver failure. Curr Opin Gastroenterol 2010;26:214-21. [PMID: 20216412 DOI: 10.1097/MOG.0b013e32833847c5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
329 Gu X, Albrecht W, Edlund K, Kappenberg F, Rahnenführer J, Leist M, Moritz W, Godoy P, Cadenas C, Marchan R, Brecklinghaus T, Pardo LT, Castell JV, Gardner I, Han B, Hengstler JG, Stoeber R. Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes. Arch Toxicol 2018;92:3505-15. [DOI: 10.1007/s00204-018-2302-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 7.7] [Reference Citation Analysis]
330 Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KB, Reddy KR, Haynes K, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA, Lo Re V. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015;148:1353-61.e3. [PMID: 25733099 DOI: 10.1053/j.gastro.2015.02.050] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
331 Zhang W, Chen B, Chen Y, Chamberland R, Fider-Whyte A, Craig J, Varma C, Befeler AS, Bisceglie AM, Horton P, Lai JP. Epstein-Barr Virus-Associated Acute Liver Failure Present in a 67-Year-Old Immunocompetent Female. Gastroenterology Res 2016;9:74-8. [PMID: 27785330 DOI: 10.14740/gr718e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
332 Kim TS, Joh JW, Moon H, Lee S, Song SH, Shin M, Kim JM, Kwon CH, Kim SJ, Lee SK. The different etiology of fulminant hepatic failure (FHF) in Korea and prognostic factors in patients undergoing liver transplantation for FHF. Clin Transplant 2013;27:297-302. [PMID: 23278635 DOI: 10.1111/ctr.12055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
333 Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 59] [Article Influence: 40.5] [Reference Citation Analysis]
334 Kao WY, Su CW, Huang YS, Chou YC, Chen YC, Chung WH, Hou MC, Lin HC, Lee FY, Wu JC. Risk of oral antifungal agent-induced liver injury in Taiwanese. Br J Clin Pharmacol. 2014;77:180-189. [PMID: 23750489 DOI: 10.1111/bcp.12178] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
335 Henrique da Silva G, Barros PP, Silva Gonçalves GM, Landi MA. Hepatoprotective effect of Lycopodium clavatum 30CH on experimental model of paracetamol-induced liver damage in rats. Homeopathy 2015;104:29-35. [PMID: 25576269 DOI: 10.1016/j.homp.2014.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
336 Alanazi NS, Alenazi TS, Alenzi KA. Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury. Am J Case Rep 2021;22:e931418. [PMID: 34383728 DOI: 10.12659/AJCR.931418] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 144] [Article Influence: 14.0] [Reference Citation Analysis]
338 Shi X, Xu H, Ji W, Liang Y, Duan W, He L, Wang M, Zhao Z. Efficacy of liver transplantation for acute hepatic failure: a single-center experience. Hepatobiliary & Pancreatic Diseases International 2011;10:369-73. [DOI: 10.1016/s1499-3872(11)60062-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
339 Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;3:56. [PMID: 23091461 DOI: 10.3389/fphys.2012.00056] [Cited by in Crossref: 141] [Cited by in F6Publishing: 133] [Article Influence: 15.7] [Reference Citation Analysis]
340 Jyothi Reddy G, Prasanth Reddy V, Sreepavani M, Rajaram C, Nelson Kumar S, Kanhere RS. Evaluation of hepatoprotective potential of ethanolic extract of Ixora pavetta against isoniazid and rifampicin induced hepatotoxicity in rats. Drug Invention Today 2013;5:201-6. [DOI: 10.1016/j.dit.2013.06.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
341 Sundaram V, Shah P, Wong RJ, Karvellas CJ, Fortune BE, Mahmud N, Kuo A, Jalan R. Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients. Hepatology 2019;70:334-45. [PMID: 30908660 DOI: 10.1002/hep.30624] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
342 Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review. Intensive Care Med. 2010;36:210-213. [PMID: 19847396 DOI: 10.1007/s00134-009-1702-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
343 Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009;155:801-806.e1. [PMID: 19643443 DOI: 10.1016/j.jpeds.2009.06.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 59] [Article Influence: 7.7] [Reference Citation Analysis]
344 Shan S, Shen Z, Song F. Autophagy and acetaminophen-induced hepatotoxicity. Arch Toxicol 2018;92:2153-61. [PMID: 29876591 DOI: 10.1007/s00204-018-2237-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
345 Chen M, Bisgin H, Tong L, Hong H, Fang H, Borlak J, Tong W. Toward predictive models for drug-induced liver injury in humans: are we there yet? Biomark Med. 2014;8:201-213. [PMID: 24521015 DOI: 10.2217/bmm.13.146] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 13.3] [Reference Citation Analysis]
346 Matsuzaka Y, Hosaka T, Ogaito A, Yoshinari K, Uesawa Y. Prediction Model of Aryl Hydrocarbon Receptor Activation by a Novel QSAR Approach, DeepSnap-Deep Learning. Molecules 2020;25:E1317. [PMID: 32183141 DOI: 10.3390/molecules25061317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
347 Lee CH, Wang JD, Chen PC. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 2010;19:708-14. [PMID: 20582911 DOI: 10.1002/pds.1966] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
348 Beersma MF, Verjans GM, Metselaar HJ, Osterhaus AD, Berrington WR, van Doornum GJ. Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis. J Viral Hepat. 2011;18:e160-e166. [PMID: 20704650 DOI: 10.1111/j.1365-2893.2010.01352.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
349 Buechter M, Gerken G, Hoyer DP, Bertram S, Theysohn JM, Thodou V, Kahraman A. Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report. BMC Anesthesiol 2018;18:71. [PMID: 29925334 DOI: 10.1186/s12871-018-0538-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
350 Sales I, Dzierba AL, Smithburger PL, Rowe D, Kane-gill SL. Use of acetylcysteine for non-acetaminophen-induced acute liver failure. Annals of Hepatology 2013;12:6-10. [DOI: 10.1016/s1665-2681(19)31379-1] [Cited by in Crossref: 23] [Article Influence: 2.9] [Reference Citation Analysis]
351 Kuznietsova H, Lynchak O, Dziubenko N, Herheliuk T, Prylutskyy Y, Rybalchenko V, Ritter U. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury. Bioimpacts 2019;9:227-37. [PMID: 31799159 DOI: 10.15171/bi.2019.28] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
352 Masson MJ, Collins LA, Carpenter LD, Graf ML, Ryan PM, Bourdi M, Pohl LR. Pathologic role of stressed-induced glucocorticoids in drug-induced liver injury in mice. Biochem Biophys Res Commun 2010;397:453-8. [PMID: 20510877 DOI: 10.1016/j.bbrc.2010.05.126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
353 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson's disease without cirrhosis: A case report. World J Gastroenterol 2018;24:290-6. [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
354 Tan EH, Ling ZJ, Ang PS, Sung C, Dan YY, Tai BC. Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance. Pharmacoepidemiol Drug Saf 2020;29:1480-8. [PMID: 32844466 DOI: 10.1002/pds.5099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, Sangfelt P, Danielsson Å, Sandberg-gertzén H, Lööf L, Prytz H, Björnsson E. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007;262:393-401. [DOI: 10.1111/j.1365-2796.2007.01818.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 81] [Article Influence: 7.7] [Reference Citation Analysis]
356 Devarbhavi H. Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management. Curr Hepatology Rep 2017;16:276-85. [DOI: 10.1007/s11901-017-0367-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
357 Jalan R. Acute liver failure: current management and future prospects. J Hepatol. 2005;42 Suppl:S115-S123. [PMID: 15777566 DOI: 10.1016/j.jhep.2004.11.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
358 Louvet A, Ntandja Wandji LC, Lemaître E, Khaldi M, Lafforgue C, Artru F, Quesnel B, Lassailly G, Dharancy S, Mathurin P. Acute Liver Injury With Therapeutic Doses of Acetaminophen: A Prospective Study. Hepatology 2021;73:1945-55. [PMID: 33306215 DOI: 10.1002/hep.31678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
359 Urban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly AK, Aithal GP, Dillon J, Navarro V, Odin J, Barnhart H, Ostrov D, Long N, Cirulli ET, Watkins PB, Fontana RJ; Drug-Induced Liver Injury Network (DILIN)., Pharmacogenetics of Drug-Induced Liver Injury group (DILIGEN)., International Serious Adverse Events Consortium (iSAEC). Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. J Hepatol 2017;67:137-44. [PMID: 28323125 DOI: 10.1016/j.jhep.2017.03.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
360 Fujiwara K, Yasui S, Nakano M, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Oda S, Yokosuka O. Severe and fulminant hepatitis of indeterminate etiology in a Japanese center: Acute liver failure of indeterminate etiology. Hepatol Res 2015;45:E141-9. [DOI: 10.1111/hepr.12483] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
361 Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011;54:1767-1776. [PMID: 22045675 DOI: 10.1002/hep.24538] [Cited by in Crossref: 379] [Cited by in F6Publishing: 337] [Article Influence: 42.1] [Reference Citation Analysis]
362 Tsutsui A, Nakanuma Y, Takaguchi K, Nakamura S, Shibata H, Baba N, Senoh T, Nagano T, Ikeda H. Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury. Mediators Inflamm. 2015;2015:913793. [PMID: 26783385 DOI: 10.1155/2015/913793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
363 Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P. Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol 2009;15:4865-76. [PMID: 19842215 DOI: 10.3748/wjg.15.4865] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 70] [Article Influence: 7.5] [Reference Citation Analysis]
364 Bacak SJ, Thornburg LL. Liver Failure in Pregnancy. Critical Care Clinics 2016;32:61-72. [DOI: 10.1016/j.ccc.2015.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
365 Urfi MK, Mujahid M, Rahman MA, Rahman MA. The Role of Tamarix gallica Leaves Extract in Liver Injury Induced by Rifampicin Plus Isoniazid in Sprague Dawley Rats. J Diet Suppl. 2018;15:24-33. [PMID: 28459346 DOI: 10.1080/19390211.2017.1310783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
366 Luber RP, Rentsch C, Lontos S, Pope JD, Aung AK, Schneider HG, Kemp W, Roberts SK, Majeed A. Turmeric induced liver injury: A report of two cases. Case Reports Hepatol. 2019;2019:6741213. [PMID: 31214366 DOI: 10.1155/2019/6741213] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
367 Singhal S, Chakravarty A, Das BC, Kar P. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure. Biomarkers. 2009;14:347-353. [PMID: 19505222 DOI: 10.1080/13547500903013664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
368 Kim CW, Park JS, Oh SH, Park JH, Shim HI, Yoon JW, Park JS, Hong SB, Kim JM, Le TB, Lee JW. Drug-induced liver injury caused by iodine-131. Clin Mol Hepatol 2016;22:272-5. [PMID: 27209646 DOI: 10.3350/cmh.2015.0037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
369 Assis DN, Navarro VJ. Human drug hepatotoxicity: a contemporary clinical perspective. Expert Opin Drug Metab Toxicol 2009;5:463-73. [PMID: 19416083 DOI: 10.1517/17425250902927386] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
370 Mallet M, Weiss N, Thabut D, Rudler M. Why and when to measure ammonemia in cirrhosis? Clin Res Hepatol Gastroenterol 2018;42:505-11. [PMID: 29551609 DOI: 10.1016/j.clinre.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
371 Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, Vikram HR. Fulminant hepatitis due to human adenovirus. Infection. 2014;42:105-111. [PMID: 23979854 DOI: 10.1007/s15010-013-0527-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
372 Butler DC, Lewin DN, Batalis NI. Differential Diagnosis of Hepatic Necrosis Encountered at Autopsy. Acad Forensic Pathol 2018;8:256-95. [PMID: 31240042 DOI: 10.1177/1925362118782056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
373 Njoku DB. Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. Int J Mol Sci. 2014;15:6990-7003. [PMID: 24758937 DOI: 10.3390/ijms15046990] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
374 Reddyhoff D, Ward J, Williams D, Regan S, Webb S. Timescale analysis of a mathematical model of acetaminophen metabolism and toxicity. J Theor Biol 2015;386:132-46. [PMID: 26348886 DOI: 10.1016/j.jtbi.2015.08.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
375 Srivastava A, Maggs JL, Antoine DJ, Williams DP, Smith DA, Park BK. Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol. 2010;196:165-194. [PMID: 20020263 DOI: 10.1007/978-3-642-00663-0_7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 67] [Article Influence: 7.9] [Reference Citation Analysis]
376 Vinholt Schiødt F, Lee WM. Fulminant liver disease. Clinics in Liver Disease 2003;7:331-49. [DOI: 10.1016/s1089-3261(03)00026-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
377 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002018-200932010-00005.] [Reference Citation Analysis]
378 Flynn NR, Dang NL, Ward MD, Swamidass SJ. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model 2020;60:3431-49. [DOI: 10.1021/acs.jcim.0c00361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
379 Xu Q, Fan Y, Loor JJ, Liang Y, Sun X, Jia H, Zhao C, Xu C. Cardamonin Reduces Acetaminophen-Induced Acute Liver Injury in Mice via Activating Autophagy and NFE2L2 Signaling. Front Pharmacol 2020;11:601716. [PMID: 33364966 DOI: 10.3389/fphar.2020.601716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
380 Singh D, Cho WC, Upadhyay G. Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview. Front Physiol 2015;6:363. [PMID: 26858648 DOI: 10.3389/fphys.2015.00363] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
381 Björnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica 2008;118:281-90. [DOI: 10.1111/j.1600-0404.2008.01009.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
382 Frontera JA. Metabolic encephalopathies in the critical care unit. Continuum (Minneap Minn) 2012;18:611-39. [PMID: 22810252 DOI: 10.1212/01.CON.0000415431.07019.c2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
383 Bonkovsky HL, Barnhart HX, Foureau DM, Steuerwald N, Lee WM, Gu J, Fontana RJ, Hayashi PJ, Chalasani N, Navarro VM, Odin J, Stolz A, Watkins PB, Serrano J; US Drug-Induced Liver Injury Network and the Acute Liver Failure Study Group. Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLoS One 2018;13:e0206389. [PMID: 30359443 DOI: 10.1371/journal.pone.0206389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
384 Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, Bruce K, Johnson S, Talwalkar J, Shen Y, Ellis S, Kullo I, Chute C, Friedman C, Bottinger E, Hripcsak G, Weng C. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc 2013;20:e243-52. [PMID: 23837993 DOI: 10.1136/amiajnl-2013-001930] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
385 Yang J, Sun H, Liu Q. The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2016;2016:5802674. [PMID: 27148364 DOI: 10.1155/2016/5802674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
386 Rotundo L, Pyrsopoulos N. Liver injury induced by paracetamol and challenges associated with intentional and unintentional use. World J Hepatol 2020;12:125-36. [PMID: 32685105 DOI: 10.4254/wjh.v12.i4.125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
387 Handler SM, Shirts BH, Perera S, Becich MJ, Castle NG, Hanlon JT. Frequency of laboratory monitoring of chronic medications administered to nursing facility residents: results of a national Internet-based study. Consult Pharm 2008;23:387-95. [PMID: 18540792 DOI: 10.4140/tcp.n.2008.387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
388 Samuel D, Ichai P. Prognosis indicator in acute liver failure: Is there a place for cell death markers? J Hepatol 2010;53:593-5. [PMID: 20619915 DOI: 10.1016/j.jhep.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
389 Costa-Moreira P, Gaspar R, Pereira P, Lopes S, Canão P, Lopes J, Carneiro F, Macedo G. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital. Virchows Arch 2020;477:517-25. [PMID: 32377873 DOI: 10.1007/s00428-020-02824-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
390 Fontana RJ, Bari K. Acute Liver Failure. In: Schiff ER, Maddrey WC, Reddy KR, editors. Schiff's Diseases of the Liver. Oxford: John Wiley & Sons, Ltd; 2017. pp. 411-31. [DOI: 10.1002/9781119251316.ch17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
391 Njoku DB, Talor MV, Fairweather D, Frisancho-Kiss S, Odumade OA, Rose NR. A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse. Exp Mol Pathol 2005;78:87-100. [PMID: 15713433 DOI: 10.1016/j.yexmp.2004.10.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
392 Larrey D, Pageaux GP. Drug-induced acute liver failure. Eur J Gastroenterol Hepatol. 2005;17:141-143. [PMID: 15674089 DOI: 10.1097/00042737-200502000-00002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
393 Spraggs CF, Xu C, Hunt CM. Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors. Pharmacogenomics 2013;14:541-54. [DOI: 10.2217/pgs.13.24] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
394 Lee WM. Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failure. Hepatology 2004;40:6-9. [DOI: 10.1002/hep.20293] [Cited by in Crossref: 307] [Cited by in F6Publishing: 267] [Article Influence: 18.1] [Reference Citation Analysis]
395 Karnes JH, Miller MA, White KD, Konvinse KC, Pavlos RK, Redwood AJ, Peter JG, Lehloenya R, Mallal SA, Phillips EJ. Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Annu Rev Pharmacol Toxicol 2019;59:463-86. [PMID: 30134124 DOI: 10.1146/annurev-pharmtox-010818-021818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
396 Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16:3041-53. [PMID: 19689281 DOI: 10.2174/092986709788803097] [Cited by in Crossref: 231] [Cited by in F6Publishing: 190] [Article Influence: 19.3] [Reference Citation Analysis]
397 Abdallah MA, Abdalla A, Ellithi M, Abdalla AO, Cunningham AG, Yeddi A, Rajendiran G. Turmeric-Associated Liver Injury. Am J Ther 2020;27:e642-5. [PMID: 31283536 DOI: 10.1097/MJT.0000000000001025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
398 Zhang YV, Fan S, Kellogg MD. Effect of hemolysis, icterus, and lipemia on three acetaminophen assays: Potential medical consequences of false positive results. Clinica Chimica Acta 2018;487:287-92. [DOI: 10.1016/j.cca.2018.10.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
399 Kamat P, Kunde S, Vos M, Vats A, Gupta N, Heffron T, Romero R, Fortenberry JD. Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med 2012;13:e33-8. [PMID: 21263362 DOI: 10.1097/PCC.0b013e31820ac08f] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 3.4] [Reference Citation Analysis]
400 Sentürk E, Esen F, Ozcan PE, Rifai K, Pinarbaşi B, Cakar N, Telci L. The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications. J Clin Apher 2010;25:195-201. [PMID: 20818714 DOI: 10.1002/jca.20238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
401 Hay JE. Acute Liver Failure. Curr Treat Options Gastroenterol 2004;7:459-68. [PMID: 15527712 DOI: 10.1007/s11938-004-0005-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
402 Bartnik CM, Maheshwari RN, Subramanian RM. Beating the Odds: A Full-Term Delivery After Liver Transplantation of a Pregnant Hyperthyroid Patient at 19 Weeks' Gestation for Propylthiouracil-Induced Acute Liver Failure. Transplant Proc. 2018;50:3995-3999. [PMID: 30577302 DOI: 10.1016/j.transproceed.2018.06.046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
403 Flynn TJ, Ferguson MS. An in vitro system for studying potential biological mechanisms of human sex differences in susceptibility to acute liver injury. Toxicology Letters 2010;198:232-6. [DOI: 10.1016/j.toxlet.2010.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
404 Mcburney RN, Hines WM, Von Tungeln LS, Schnackenberg LK, Beger RD, Moland CL, Tao Han, Fuscoe JC, Chang C, Chen JJ, Zhenqiang Su, Fan X, Weida Tong, Booth SA, Balasubramanian R, Courchesne PL, Campbell JM, Graber A, Yu Guo, Juhasz PJ, Li TY, Lynch MD, Morel NM, Plasterer TN, Takach EJ, Chenhui Zeng, Beland FA. The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results. Toxicol Pathol 2009;37:52-64. [DOI: 10.1177/0192623308329287] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
405 Thusius NJ, Romanowicz M, Bostwick JM. Intentional or Inadvertent Acetaminophen Overdose-How Lethal It Really Is? Psychosomatics 2019;60:574-81. [PMID: 31202442 DOI: 10.1016/j.psym.2019.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
406 Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009;30:71-87, viii. [PMID: 19186281 DOI: 10.1016/j.ccm.2008.10.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
407 Ho CM, Lee CH, Wang JY, Lee PH, Lai HS, Hu RH. Nationwide longitudinal analysis of acute liver failure in taiwan. Medicine (Baltimore) 2014;93:e35. [PMID: 25068951 DOI: 10.1097/MD.0000000000000035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
408 Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol. 2015;50:439-446. [PMID: 25639449 DOI: 10.3109/00365521.2014.958094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
409 Im SG, Yoo SH, Jeon DO, Cho HJ, Choi JY, Paik S, Park YM. Chelidonium majus -Induced Acute Hepatitis. Ewha Med J 2014;37:60. [DOI: 10.12771/emj.2014.37.1.60] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
410 Kumar R, Bhatia V, Khanal S, Sreenivas V, Gupta SD, Panda SK, Acharya SK; Shalimar. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology 2010;51:1665-74. [PMID: 20196116 DOI: 10.1002/hep.23534] [Cited by in Crossref: 91] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
411 Shin SM, Yang JH, Ki SH. Role of the Nrf2-ARE pathway in liver diseases. Oxid Med Cell Longev. 2013;2013:763257. [PMID: 23766860 DOI: 10.1155/2013/763257] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 12.4] [Reference Citation Analysis]
412 Tan CY, Saw TY, Fong CW, Ho HK. Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injury. Redox Biol 2015;4:308-20. [PMID: 25637740 DOI: 10.1016/j.redox.2015.01.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
413 Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf. 2007;6:673-684. [PMID: 17967156 DOI: 10.1517/14740338.6.6.673] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 8.6] [Reference Citation Analysis]
414 Iruzubieta P, Arias-Loste MT, Barbier-Torres L, Martinez-Chantar ML, Crespo J. The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role? Biomed Res Int 2015;2015:386186. [PMID: 26824035 DOI: 10.1155/2015/386186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
415 Mobasher MA, Valverde ÁM. Signalling pathways involved in paracetamol-induced hepatotoxicity: new insights on the role of protein tyrosine phosphatase 1B. Archives of Physiology and Biochemistry 2014;120:51-63. [DOI: 10.3109/13813455.2014.893365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
416 Yeap V, Tan TJY, Loh T, Kumar R. Liver failure associated with mahogany seed extract consumption.BMJ Case Rep. 2018;bcr-2018. [PMID: 30061133 DOI: 10.1136/bcr-2018-225382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
417 Rowden AK, Norvell J, Eldridge DL, Kirk MA. Updates on Acetaminophen Toxicity. Medical Clinics of North America 2005;89:1145-59. [DOI: 10.1016/j.mcna.2005.06.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
418 Lewis JH, Kleiner DE. Hepatic injury due to drugs, herbal compounds, chemicals and toxins. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 645-760. [DOI: 10.1016/b978-0-7020-3398-8.00013-1] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
419 Su Kim H, Seon Kim H, Yoon Lee J, Sun Jang J, Geon Shin W, Ho Kim K, Yong Park J, Heon Lee J, Yang Kim H, Kuk Jang M. Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A. Scandinavian Journal of Gastroenterology 2009;43:81-8. [DOI: 10.1080/00365520701514578] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
420 Marroquin LD, Bonin PD, Keefer J, Schroeter T. Assessment of Bile Salt Export Pump (BSEP) Inhibition in Membrane Vesicles Using Radioactive and LC/MS‐Based Detection Methods. Current Protocols in Toxicology 2017;71. [DOI: 10.1002/cptx.15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
421 Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe'er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB; Drug-Induced Liver Injury Network., DILIGEN., EUDRAGENE., Spanish DILI Registry., International Serious Adverse Events Consortium. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics 2012;22:784-95. [PMID: 22968431 DOI: 10.1097/FPC.0b013e3283589a76] [Cited by in Crossref: 90] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
422 Lodge JPA, Dasgupta D, Prasad KR, Attia M, Toogood GJ, Davies M, Millson C, Breslin N, Wyatt J, Robinson PJ, Bellamy MC, Snook N, Pollard SG. Emergency Subtotal Hepatectomy: A New Concept for Acetaminophen-Induced Acute Liver Failure: Temporary Hepatic Support by Auxiliary Orthotopic Liver Transplantation Enables Long-term Success. Annals of Surgery 2008;247:238-49. [DOI: 10.1097/sla.0b013e31816401ec] [Cited by in Crossref: 38] [Cited by in F6Publishing: 2] [Article Influence: 2.9] [Reference Citation Analysis]
423 Wolf MS, King J, Jacobson K, Di Francesco L, Bailey SC, Mullen R, McCarthy D, Serper M, Davis TC, Parker RM. Risk of unintentional overdose with non-prescription acetaminophen products. J Gen Intern Med. 2012;27:1587-1593. [PMID: 22638604 DOI: 10.1007/s11606-012-2096-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
424 Dryden MDM, Rackus DDG, Shamsi MH, Wheeler AR. Integrated Digital Microfluidic Platform for Voltammetric Analysis. Anal Chem 2013;85:8809-16. [DOI: 10.1021/ac402003v] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
425 Ghabril M, Chalasani N, Björnsson E. Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol 2010;26:222-6. [PMID: 20186054 DOI: 10.1097/MOG.0b013e3283383c7c] [Cited by in Crossref: 82] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
426 Kantola T, Mäklin S, Koivusalo AM, Räsänen P, Rissanen A, Roine R, Sintonen H, Höckerstedt K, Isoniemi H. Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure. World J Gastroenterol 2010;16:2227-34. [PMID: 20458759 DOI: 10.3748/wjg.v16.i18.2227] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
427 Woodhead JL, Howell BA, Yang Y, Harrill AH, Clewell HJ, Andersen ME, Siler SQ, Watkins PB. An Analysis of N -Acetylcysteine Treatment for Acetaminophen Overdose Using a Systems Model of Drug-Induced Liver Injury. J Pharmacol Exp Ther 2012;342:529-40. [DOI: 10.1124/jpet.112.192930] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
428 Montrief T, Koyfman A, Long B. Acute liver failure: A review for emergency physicians. Am J Emerg Med 2019;37:329-37. [PMID: 30414744 DOI: 10.1016/j.ajem.2018.10.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
429 Zhu B, You SL, Wan ZH, Liu HL, Rong YH, Zang H, Xin SJ. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure. World J Gastroenterol 2014;20:7473-9. [PMID: 24966618 DOI: 10.3748/wjg.v20.i23.7473] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
430 Wang MC, Wandrer F, Schlué J, Voigtländer T, Lankisch TO, Manns MP, Bantel H, von Hahn T. Transjugular diagnostics in acute liver failure including measurements of hepatocentral venous biomarker gradients: Transjugular diagnostics in acute liver failure. Hepatol Res 2018;48:914-25. [DOI: 10.1111/hepr.13185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
431 Jayakumar S, Chowdhury R, Ye C, Karvellas CJ. Fulminant viral hepatitis. Crit Care Clin. 2013;29:677-697. [PMID: 23830658 DOI: 10.1016/j.ccc.2013.03.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
432 Singanayagam A, Bernal W. Update on acute liver failure: . Current Opinion in Critical Care 2015;21:134-41. [DOI: 10.1097/mcc.0000000000000187] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 6.2] [Reference Citation Analysis]
433 Myers RP, Li B, Fong A, Shaheen AA, Quan H. Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health 2007;7:143. [PMID: 17615056 DOI: 10.1186/1471-2458-7-143] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
434 Hadem J, Tacke F, Bruns T, Langgartner J, Strnad P, Denk GU, Fikatas P, Manns MP, Hofmann WP, Gerken G, Grünhage F, Umgelter A, Trautwein C, Canbay A; Acute Liver Failure Study Group Germany. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol 2012;10:664-9.e2. [PMID: 22373724 DOI: 10.1016/j.cgh.2012.02.016] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 9.8] [Reference Citation Analysis]
435 Suk KT, Kim DJ. Drug-induced liver injury: present and future. Clin Mol Hepatol. 2012;18:249-257. [PMID: 23091804 DOI: 10.3350/cmh.2012.18.3.249] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
436 Hussein R, El-halabi M, Ghaith O, Jurdi N, Azar C, Mansour N, Sharara AI. Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole. Arab Journal of Gastroenterology 2011;12:44-7. [DOI: 10.1016/j.ajg.2010.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
437 Karvellas CJ, Cardoso FS, Gottfried M, Reddy KR, Hanje AJ, Ganger D, Lee WM;  US Acute Liver Failure Study Group. HBV-Associated Acute Liver Failure After Immunosuppression and Risk of Death. Clin Gastroenterol Hepatol. 2017;15:113-122. [PMID: 27311622 DOI: 10.1016/j.cgh.2016.06.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
438 Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, González-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R; Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512-21. [PMID: 16083708 DOI: 10.1016/j.gastro.2005.05.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
439 Xue F, Strombom I, Turnbull B, Zhu S, Seeger JD. Duloxetine for depression and the incidence of hepatic events in adults. J Clin Psychopharmacol. 2011;31:517-522. [PMID: 21694615 DOI: 10.1097/jcp.0b013e31822347d9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
440 Fan WL, Shiao MS, Hui RC, Su SC, Wang CW, Chang YC, Chung WH. HLA Association with Drug-Induced Adverse Reactions. J Immunol Res 2017;2017:3186328. [PMID: 29333460 DOI: 10.1155/2017/3186328] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
441 Fontana RJ, Stravitz RT, Durkalski V, Hanje J, Hameed B, Koch D, Ganger D, Olson J, Liou I, McGuire BM, Clasen K, Lee WM. Prognostic Value of the 13 C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury. Hepatology 2021;74:961-72. [PMID: 33660316 DOI: 10.1002/hep.31783] [Reference Citation Analysis]
442 Moon MS, Richie JP, Isom HC. Iron potentiates acetaminophen-induced oxidative stress and mitochondrial dysfunction in cultured mouse hepatocytes. Toxicol Sci 2010;118:119-27. [PMID: 20667997 DOI: 10.1093/toxsci/kfq230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
443 Camarata MA, Gottfried M, Rule JA, Ala A, Lee WM, Todd Stravitz R, Schilsky ML. Outcomes of Acute Liver Injury in Adults Due to Wilson's Disease: Is Survival Without Transplant Possible? Liver Transpl. 2020;26:330-336. [PMID: 31838773 DOI: 10.1002/lt.25703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
444 Ford RM, Sakaria SS, Subramanian RM. Critical care management of patients before liver transplantation. Transplant Rev (Orlando) 2010;24:190-206. [PMID: 20688502 DOI: 10.1016/j.trre.2010.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
445 Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl. 2005;11:594-605. [PMID: 15915484 DOI: 10.1002/lt.20435] [Cited by in Crossref: 114] [Cited by in F6Publishing: 82] [Article Influence: 7.1] [Reference Citation Analysis]
446 Sundaram V, Shaikh OS. Acute liver failure: current practice and recent advances. Gastroenterol Clin North Am 2011;40:523-39. [PMID: 21893272 DOI: 10.1016/j.gtc.2011.06.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
447 Xia L, Xiao T. An unusual case of autoimmune hepatitis in a patient with adult-onset Still’s disease. Clin Rheumatol 2010;29:95-7. [DOI: 10.1007/s10067-009-1186-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
448 Eipel C, Kidess E, Abshagen K, Leminh K, Menger MD, Burkhardt H, Vollmar B. Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D-galactosamine-sensitized mice to lipopolysaccharide. Br J Pharmacol. 2007;151:406-413. [PMID: 17420780 DOI: 10.1038/sj.bjp.0707230] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
449 Mishra A, Rustgi V. Prognostic Models in Acute Liver Failure. Clin Liver Dis. 2018;22:375-388. [PMID: 29605072 DOI: 10.1016/j.cld.2018.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
450 Hessheimer AJ, Nacif L, Flores Villalba E, Fondevila C. Liver transplantation for acute liver failure. Cir Esp 2017;95:181-9. [PMID: 28433231 DOI: 10.1016/j.ciresp.2017.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
451 Salek J, Byrne J, Box T, Longo N, Sussman N. Recurrent liver failure in a 25-year-old female. Liver Transpl 2010;16:1049-53. [DOI: 10.1002/lt.22118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
452 Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology. 2008;48:1336-1341. [PMID: 18821593 DOI: 10.1002/hep.22536] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
453 Becker EP, Sun D, Minuk GY. Exogenous adenosine 5'-triphosphate does not improve survival in rats with acute liver failure. Dig Dis Sci 2008;53:794-8. [PMID: 17934848 DOI: 10.1007/s10620-007-9940-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
454 Cheng L, You Q, Yin H, Holt MP, Ju C. Involvement of natural killer T cells in halothane-induced liver injury in mice. Biochem Pharmacol. 2010;80:255-261. [PMID: 20359463 DOI: 10.1016/j.bcp.2010.03.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
455 Kim M, Yun JW, Shin K, Cho Y, Yang M, Nam KT, Lim KM. Expression Levels of GABA-A Receptor Subunit Alpha 3, Gabra3 and Lipoprotein Lipase, Lpl Are Associated with the Susceptibility to Acetaminophen-Induced Hepatotoxicity. Biomol Ther (Seoul) 2017;25:112-21. [PMID: 27530116 DOI: 10.4062/biomolther.2016.076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
456 Nam EJ, Hayashida K, Aquino RS, Couchman JR, Kozar RA, Liu J, Park PW. Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice. Hepatology 2017;66:1601-15. [PMID: 28543100 DOI: 10.1002/hep.29265] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
457 Pamecha V, Vagadiya A, Sinha PK, Sandhyav R, Parthasarathy K, Sasturkar S, Mohapatra N, Choudhury A, Maiwal R, Khanna R, Alam S, Pandey CK, Sarin SK. Living Donor Liver Transplantation for Acute Liver Failure: Donor Safety and Recipient Outcome. Liver Transpl. 2019;25:1408-1421. [PMID: 30861306 DOI: 10.1002/lt.25445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
458 Holt M, Ju C. Drug-Induced Liver Injury. In: Uetrecht J, editor. Adverse Drug Reactions. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-27. [DOI: 10.1007/978-3-642-00663-0_1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
459 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002] [Reference Citation Analysis]
460 Foston TP, Carpentar D. Acute liver failure. Crit Care Nurs Clin North Am. 2010;22:395-402. [PMID: 20691389 DOI: 10.1016/j.ccell.2010.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
461 Bartels S, Sivilotti M, Crosby D, Richard J. Are recommended doses of acetaminophen hepatotoxic for recently abstinent alcoholics? A randomized trial. Clinical Toxicology 2009;46:243-9. [DOI: 10.1080/15563650701447020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
462 Heard K, Green JL, Bailey JE, Bogdan GM, Dart RC. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther 2007;26:283-90. [PMID: 17593074 DOI: 10.1111/j.1365-2036.2007.03368.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
463 Kowalec K, Wright GEB, Drögemöller BI, Aminkeng F, Bhavsar AP, Kingwell E, Yoshida EM, Traboulsee A, Marrie RA, Kremenchutzky M, Campbell TL, Duquette P, Chalasani N, Wadelius M, Hallberg P, Xia Z, De Jager PL, Denny JC, Davis MF, Ross CJD, Tremlett H, Carleton BC. Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis. Nat Genet 2018;50:1081-5. [PMID: 30013178 DOI: 10.1038/s41588-018-0168-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
464 Douros A, Azoulay L, Yin H, Suissa S, Renoux C. Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury. J Am Coll Cardiol 2018;71:1105-13. [PMID: 29519351 DOI: 10.1016/j.jacc.2018.01.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
465 Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2007;11:525-548, vi. [PMID: 17723918 DOI: 10.1016/j.cld.2007.06.006] [Cited by in Crossref: 261] [Cited by in F6Publishing: 221] [Article Influence: 18.6] [Reference Citation Analysis]
466 Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med. 2016;164:724-732. [PMID: 27043883 DOI: 10.7326/m15-2211] [Cited by in Crossref: 163] [Cited by in F6Publishing: 53] [Article Influence: 32.6] [Reference Citation Analysis]
467 Kaplan BL, Li J, LaPres JJ, Pruett SB, Karmaus PW. Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology. Toxicol Sci 2015;145:214-32. [PMID: 26008184 DOI: 10.1093/toxsci/kfv060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
468 Lai R, Xiang X, Mo R, Bao R, Wang P, Guo S, Zhao G, Gui H, Wang H, Bao S. Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury. J Hepatol. 2015;63:148-155. [PMID: 25681556 DOI: 10.1016/j.jhep.2015.02.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
469 Vigo MB, Pérez MJ, De Fino F, Gómez G, Martínez SA, Bisagno V, Di Carlo MB, Scazziota A, Manautou JE, Ghanem CI. Acute acetaminophen intoxication induces direct neurotoxicity in rats manifested as astrogliosis and decreased dopaminergic markers in brain areas associated with locomotor regulation. Biochemical Pharmacology 2019;170:113662. [DOI: 10.1016/j.bcp.2019.113662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
470 Kouklakis; G, Mpoumponaris; A, Zezos; P, Moschos; J, Koulaouzidis; A, Nakos; A, Pehlivanidis; A, Iosiphidis; M, Molyvas; E, Nikolaidis N. Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole. Annals of Hepatology 2007;6:63-5. [DOI: 10.1016/s1665-2681(19)31956-8] [Cited by in Crossref: 19] [Article Influence: 1.4] [Reference Citation Analysis]
471 Carlisle EM, Angelos P, Siegler M, Testa G. Adult living-related liver donation for acute liver failure: is it ethically appropriate? Clin Transplant 2011;25:813-20. [PMID: 21320164 DOI: 10.1111/j.1399-0012.2011.01413.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
472 Schiødt FV, Rossaro L, Stravitz RT, Shakil AO, Chung RT, Lee WM. Gc-globulin and prognosis in acute liver failure. Liver Transpl. 2005;11:1223-1227. [PMID: 16184570 DOI: 10.1002/lt.20437] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
473 Yu JW, Sun LJ, Zhao YH, Kang P, Li SC. The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci. 2010;55:775-783. [PMID: 19957031 DOI: 10.1007/s10620-009-1060-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
474 Hiemstra S, Ramaiahgari SC, Wink S, Callegaro G, Coonen M, Meerman J, Jennen D, van den Nieuwendijk K, Dankers A, Snoeys J, de Bont H, Price L, van de Water B. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability. Arch Toxicol 2019;93:2895-911. [DOI: 10.1007/s00204-019-02552-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
475 Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH, Davern TJ, Lee WM, Lok AS. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat. 2005;12:192-198. [PMID: 15720535 DOI: 10.1111/j.1365-2893.2005.00581.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 5.8] [Reference Citation Analysis]
476 Cosgrove BD, King BM, Hasan MA, Alexopoulos LG, Farazi PA, Hendriks BS, Griffith LG, Sorger PK, Tidor B, Xu JJ, Lauffenburger DA. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol Appl Pharmacol 2009;237:317-30. [PMID: 19362101 DOI: 10.1016/j.taap.2009.04.002] [Cited by in Crossref: 106] [Cited by in F6Publishing: 91] [Article Influence: 8.8] [Reference Citation Analysis]
477 Gomes ESR, Marques ML, Regateiro FS. Epidemiology and Risk Factors for Severe Delayed Drug Hypersensitivity Reactions. Curr Pharm Des 2019;25:3799-812. [PMID: 31694518 DOI: 10.2174/1381612825666191105115346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
478 King JP, McCarthy DM, Serper M, Jacobson KL, Mullen RJ, Parker RM, Wolf MS. Variability in Acetaminophen Labeling Practices: a Missed Opportunity to Enhance Patient Safety. J Med Toxicol 2015;11:410-4. [PMID: 25697756 DOI: 10.1007/s13181-015-0464-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
479 Leventhal TM, Liu KD. What a Nephrologist Needs to Know About Acute Liver Failure. Advances in Chronic Kidney Disease 2015;22:376-81. [DOI: 10.1053/j.ackd.2015.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
480 Strnad P, Zhou Q, Hanada S, Lazzeroni LC, Zhong BH, So P, Davern TJ, Lee WM, Omary MB. Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations. Gastroenterology. 2010;139:828-835, 835.e1-e3. [PMID: 20538000 DOI: 10.1053/j.gastro.2010.06.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
481 Amacher DE, Schomaker SJ, Aubrecht J. Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics. Mol Diagn Ther 2013;17:343-54. [PMID: 23868512 DOI: 10.1007/s40291-013-0049-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
482 Cho JH, Oh DS, Hong SH, Ko H, Lee NH, Park SE, Han CW, Kim SM, Kim YC, Kim KS, Choi CW, Shin SM, Kim KT, Choi HS, Lee JH, Kim JY, Kang JY, Lee DS, Ahn YC, Son CG. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol 2017;91:4009-15. [PMID: 28634823 DOI: 10.1007/s00204-017-2007-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
483 Zhang L, Zhao Y, Fan L, Xu K, Ji F, Xie Z, Ouyang X, Wu D, Li L. Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen-activated protein kinase and TLR4/nuclear factor-κB pathways and autophagy. Phytother Res 2019;33:1055-64. [PMID: 30701601 DOI: 10.1002/ptr.6299] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
484 Eken H, Isik A, Buyukakincak S, Yilmaz I, Firat D, Cimen O. Incarceration of the hepatic lobe in incisional hernia: A case report. Ann Med Surg (Lond). 2015;4:208-210. [PMID: 26155360 DOI: 10.1016/j.amsu.2015.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
485 Gruz F, Raffa S, Santucci C, Papale RM, Videla MG, Fernández MG, Yantorno S, Descalzi VI. Agomelatine: fulminant liver failure in a patient with fatty liver. Gastroenterol Hepatol. 2014;37:92-94. [PMID: 23849766 DOI: 10.1016/j.gastrohep.2013.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
486 Moon MS, Kang BH, Krzeminski J, Amin S, Aliaga C, Zhu J, McDevitt EI, Kocher S, Richie JP, Isom HC. 3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity. Toxicol Sci 2011;124:348-58. [PMID: 21908766 DOI: 10.1093/toxsci/kfr231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
487 Thawley V. Acute Liver Injury and Failure. Vet Clin North Am Small Anim Pract 2017;47:617-30. [PMID: 28065578 DOI: 10.1016/j.cvsm.2016.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
488 Singh S, Hynan LS, Lee WM. Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig Dis Sci. 2013;58:1397-1402. [PMID: 23325162 DOI: 10.1007/s10620-012-2512-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
489 Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652-658. [PMID: 16737880 DOI: 10.1016/j.jpeds.2005.12.051] [Cited by in Crossref: 467] [Cited by in F6Publishing: 325] [Article Influence: 31.1] [Reference Citation Analysis]
490 García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 2008;27:780-789. [PMID: 18284654 DOI: 10.1111/j.1365-2036.2008.03655.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 7.9] [Reference Citation Analysis]
491 Lee WM. Drug-induced acute liver failure. Clin Liver Dis 2013;17:575-86, viii. [PMID: 24099019 DOI: 10.1016/j.cld.2013.07.001] [Cited by in Crossref: 133] [Cited by in F6Publishing: 102] [Article Influence: 16.6] [Reference Citation Analysis]
492 Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012;16:231-245. [PMID: 22541696 DOI: 10.1016/j.cld.2012.03.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
493 Stevens RD, Merritt WT. Rescuing the brain in acute liver failure*: . Critical Care Medicine 2008;36:2212-3. [DOI: 10.1097/ccm.0b013e31817e255c] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
494 Porceddu M, Buron N, Roussel C, Labbe G, Fromenty B, Borgne-Sanchez A. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol Sci 2012;129:332-45. [PMID: 22987451 DOI: 10.1093/toxsci/kfs197] [Cited by in Crossref: 126] [Cited by in F6Publishing: 29] [Article Influence: 15.8] [Reference Citation Analysis]
495 Schiødt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee WM; Acute Liver Failure Study Group. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006;12:1776-81. [DOI: 10.1002/lt.20886] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
496 Kramer L. Acute liver failure. Wien Klin Wochenschr. 2004;116:67-81. [PMID: 15008314 DOI: 10.1007/bf03040699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
497 Dong V, Sun K, Gottfried M, Cardoso FS, McPhail MJ, Stravitz RT, Lee WM, Karvellas CJ. Significant lung injury and its prognostic significance in acute liver failure: A cohort analysis. Liver Int 2020;40:654-63. [PMID: 31566904 DOI: 10.1111/liv.14268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
498 Teschke R, Bahre R, Fuchs J, Wolff A. Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases. Menopause. 2009;16:956-965. [PMID: 19339903 DOI: 10.1097/gme.0b013e31819d3904] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
499 Toyoda Y, Endo S, Tsuneyama K, Miyashita T, Yano A, Fukami T, Nakajima M, Yokoi T. Mechanism of exacerbative effect of progesterone on drug-induced liver injury. Toxicol Sci 2012;126:16-27. [PMID: 22157104 DOI: 10.1093/toxsci/kfr326] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
500 Trotter JF. Practical management of acute liver failure in the intensive care unit: . Current Opinion in Critical Care 2009;15:163-7. [DOI: 10.1097/mcc.0b013e3283293114] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
501 Kuzu UB, Öztaş E, Turhan N, Saygili F, Suna N, Yildiz H, Kaplan M, Akpinar MY, Akdoğan M, Kaçar S, Kiliç ZM, Köksal AŞ, Ödemiş B, Kayaçetin E. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis. Hepatol Res 2016;46:277-91. [PMID: 25926402 DOI: 10.1111/hepr.12530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
502 Cainelli F, Nardo B, Viderman D, Dzudzor B, Tachi K, Vento S. Treatment of Acute Liver Failure in Resource-Constrained Settings without Transplantation Facilities Can Be Improved. Front Med (Lausanne) 2016;3:31. [PMID: 27458585 DOI: 10.3389/fmed.2016.00031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
503 Squires RH, Dhawan A, Alonso E, Narkewicz MR, Shneider BL, Rodriguez-Baez N, Olio DD, Karpen S, Bucuvalas J, Lobritto S. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology. 2013;57:1542-1549. [PMID: 22886633 DOI: 10.1002/hep.26001] [Cited by in Crossref: 94] [Cited by in F6Publishing: 68] [Article Influence: 11.8] [Reference Citation Analysis]
504 Abd El-Hack ME, Samak DH, Noreldin AE, El-Naggar K, Abdo M. Probiotics and plant-derived compounds as eco-friendly agents to inhibit microbial toxins in poultry feed: a comprehensive review. Environ Sci Pollut Res Int 2018;25:31971-86. [PMID: 30229484 DOI: 10.1007/s11356-018-3197-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
505 Lucena MI, L??pez-torres E, Verge C, Andrade RJ, Puche MJ, Seoane J, de la Cuesta FS. The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment: . European Journal of Gastroenterology & Hepatology 2005;17:59-63. [DOI: 10.1097/00042737-200501000-00012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
506 Schiødt FV, Bangert K, Shakil AO, McCashland T, Murray N, Hay JE, Lee WM. Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl. 2007;13:1324-1329. [PMID: 17763387 DOI: 10.1002/lt.21236] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
507 Ash MM, Jolly PS. Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: A case study and review of vismodegib safety. Int J Dermatol. 2015;54:370-374. [PMID: 25039741 DOI: 10.1111/ijd.12543] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
508 Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH Jr, Fontana RJ, Lee WM, Schilsky ML;  Pediatric and Adult Acute Liver Failure Study Groups. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008;48:1167-1174. [PMID: 18798336 DOI: 10.1002/hep.22446] [Cited by in Crossref: 177] [Cited by in F6Publishing: 108] [Article Influence: 13.6] [Reference Citation Analysis]
509 Govindarajan R, Ramamoorthy G, Shanmugam RM, Bavanandam S, Murugesan M, Shanmugam C, Arumugam A, Chellamuthu VP, Venkatraj RK, Sampathkumar K, Rejoice P, Kumar KA, Adamali S, Mariappan K, Rathnavel R, Manivasagam VSC, Velusamy A, Arumugam S, Elikkottil TT, Dev AV, Sen M, Palaniappan A, Dorairaj AJ, Kedarisetty CK, Venkataraman J, Karthikeyan M, Somasundaram A, Ramakrishnan A, Madesh VP, Varghese J, Anupa DK, Leelakrishnan V, Swaminathan M, Kantamaneni R, Dhus JU, Murugan N, Natarajan K, Selvi C, Saithanyamurthi HV, Nadaraj A, Jeyaseelan L, Eapen CE. Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India. Indian J Gastroenterol 2021. [PMID: 34189713 DOI: 10.1007/s12664-021-01178-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Corsini A, Bortolini M. Drug-induced liver injury: the role of drug metabolism and transport. J Clin Pharmacol. 2013;53:463-474. [PMID: 23436293 DOI: 10.1002/jcph.23] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 10.5] [Reference Citation Analysis]
511 Chintamaneni P, Stevenson HL, Malik SM. Bupivacaine drug-induced liver injury: a case series and brief review of the literature. Journal of Clinical Anesthesia 2016;32:137-41. [DOI: 10.1016/j.jclinane.2016.01.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
512 Karahalil B, Hare E, Koç G, Uslu İ, Şentürk K, Özkan Y. Hepatotoxicity associated with statins. Archives of Industrial Hygiene and Toxicology 2017;68:254-60. [DOI: 10.1515/aiht-2017-68-2994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
513 Koch A, Trautwein C. N-acetylcysteine on its way to a broader application in patients with acute liver failure. Hepatology 2010;51:338-40. [PMID: 20034036 DOI: 10.1002/hep.23484] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
514 Fontana RJ, Shakil AO, Greenson JK, Boyd I, Lee WM. Acute Liver Failure Due To Amoxicillin and Amoxicillin/Clavulanate. Dig Dis Sci 2005;50:1785-90. [DOI: 10.1007/s10620-005-2938-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
515 Ng VL, Li R, Loomes KM, Leonis MA, Rudnick DA, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group (PALFSG). Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr 2016;63:357-64. [PMID: 27367788 DOI: 10.1097/MPG.0000000000001178] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
516 Davis ML, Hashemi N. Acute liver failure as a rare initial manifestation of peripheral T-cell lymphoma. World J Hepatol 2010;2:384-6. [PMID: 21160947 DOI: 10.4254/wjh.v2.i10.384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
517 McCormick PA, Treanor D, McCormack G, Farrell M. Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema. J Hepatol. 2003;39:547-551. [PMID: 12971964 DOI: 10.1016/s0168-8278(03)00299-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
518 Jalan R, Williams R, Bernuau J. Paracetamol: are therapeutic doses entirely safe? The Lancet 2006;368:2195-6. [DOI: 10.1016/s0140-6736(06)69874-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
519 Bhattacharya S, Shoda LK, Zhang Q, Woods CG, Howell BA, Siler SQ, Woodhead JL, Yang Y, McMullen P, Watkins PB, Andersen ME. Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. Front Physiol 2012;3:462. [PMID: 23248599 DOI: 10.3389/fphys.2012.00462] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
520 Siniscalchi A, Dante A, Spedicato S, Riganello L, Zanoni A, Cimatti M, Pierucci E, Bernardi E, Miklosova Z, Moretti C. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc. 2010;42:1197-1199. [PMID: 20534260 DOI: 10.1016/j.transproceed.2010.03.097] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
521 Liu W, Makrauer FL, Qamar AA, Jänne PA, Odze RD. Fulminant Hepatic Failure Secondary to Erlotinib. Clinical Gastroenterology and Hepatology 2007;5:917-20. [DOI: 10.1016/j.cgh.2007.04.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
522 Mendrick DL, Daniels KK. Biomarkers of drug-induced adverse events. Expert Review of Clinical Pharmacology 2014;1:81-91. [DOI: 10.1586/17512433.1.1.81] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
523 Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y, Opio CK, Taylor R, Restrepo R, Munoz S, Fontana RJ, Lee WM;  Acute Liver Failure Study Group. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. 2011;18:e167-e174. [PMID: 21143345 DOI: 10.1111/j.1365-2893.2010.01410.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
524 Paschoal Junior FM, Nogueira RDC, Oliveira MDL, Paschoal EHA, Teixeira MJ, D’albuquerque LAC, Bor-seng-shu E. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure. Arq Neuro-Psiquiatr 2017;75:470-6. [DOI: 10.1590/0004-282x20170076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
525 Bosoi CR, Rose CF. Brain edema in acute liver failure and chronic liver disease: similarities and differences. Neurochem Int 2013;62:446-57. [PMID: 23376027 DOI: 10.1016/j.neuint.2013.01.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
526 García-Cortés M, Ortega-Alonso A, Lucena MI, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).l. Drug-induced liver injury: a safety review. Expert Opin Drug Saf 2018;17:795-804. [PMID: 30059261 DOI: 10.1080/14740338.2018.1505861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
527 Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis 2006;10:207-17, vii. [PMID: 16971258 DOI: 10.1016/j.cld.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
528 Fontana RJ. Approaches to the Study of Drug-Induced Liver Injury. Clin Pharmacol Ther 2010;88:416-9. [DOI: 10.1038/clpt.2010.100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
529 Andrade RJ, López-Ortega S, López-Vega MC, Robles M, Cueto I, Lucena MI. Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol 2008;1:261-76. [PMID: 24422651 DOI: 10.1586/17512433.1.2.261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
530 John K, Hadem J, Krech T, Wahl K, Manns MP, Dooley S, Batkai S, Thum T, Schulze-Osthoff K, Bantel H. MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 2014;60:1346-1355. [PMID: 24913549 DOI: 10.1002/hep.27250] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
531 Shrestha DB, Budhathoki P, Sedhai YR, Adhikari A, Poudel A, Aryal B, Baniya R. N-acetyl cysteine versus standard of care for non-acetaminophen induced acute liver injury: a systematic review and meta-analysis. Ann Hepatol 2021;24:100340. [PMID: 33722689 DOI: 10.1016/j.aohep.2021.100340] [Reference Citation Analysis]
532 Khoury T, Rmeileh AA, Yosha L, Benson AA, Daher S, Mizrahi M. Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options. J Clin Transl Hepatol 2015;3:99-108. [PMID: 26356634 DOI: 10.14218/JCTH.2015.00007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
533 Njoku DB, Li Z, Washington ND, Mellerson JL, Talor MV, Sharma R, Rose NR. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury. Eur J Immunol 2009;39:1652-63. [PMID: 19499520 DOI: 10.1002/eji.200838135] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
534 Kwekel JC, Vijay V, Han T, Moland CL, Desai VG, Fuscoe JC. Sex and age differences in the expression of liver microRNAs during the life span of F344 rats. Biol Sex Differ 2017;8:6. [PMID: 28174625 DOI: 10.1186/s13293-017-0127-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
535 Ashkani-esfahani S, Bagheri F, Azarpira N, Esmaeilzadeh E, Emami Y, Hassanabadi N, Keshtkar M. Protective effects of quercetin on thioacetamide-induced acute liver damage and its related biochemical and pathological alterations. Egypt J Intern Med 2016;28:123-7. [DOI: 10.4103/1110-7782.200965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
536 Riediger C, Sauer P, Matevossian E, Müller MW, Büchler P, Friess H. Herpes simplex virus sepsis and acute liver failure. Clin Transplant. 2009;23 Suppl 21:37-41. [PMID: 19930315 DOI: 10.1111/j.1399-0012.2009.01108.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
537 Parekh J, Matei VM, Canas-Coto A, Friedman D, Lee WM; Acute Liver Failure Study Group. Budd-chiari syndrome causing acute liver failure: A multicenter case series. Liver Transpl. 2017;23:135-142. [PMID: 27656864 DOI: 10.1002/lt.24643] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
538 Bolkhir A, Loiselle M, Evon D, Hayashi P. Depression in primary caregivers of patients listed for liver or kidney transplantation. Progress in Transplantation 2007;17:193-8. [DOI: 10.7182/prtr.17.3.bx6153k7040l7031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
539 Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, Lee WM, Stolz A, Phillips T, Serrano J, Watkins PB; DILIN Investigators. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.Am J Gastroenterol. 2015;110:1450-1459. [PMID: 26346867 DOI: 10.1038/ajg.2015.283] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 10.7] [Reference Citation Analysis]
540 Hey P, Hanrahan TP, Sinclair M, Testro AG, Angus PW, Peterson A, Warrillow S, Bellomo R, Perini MV, Starkey G, Jones RM, Fink M, McClure T, Gow P. Epidemiology and outcomes of acute liver failure in Australia. World J Hepatol. 2019;11:586-595. [PMID: 31388400 DOI: 10.4254/wjh.v11.i7.586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
541 Moylan CA, Suzuki A, Papay JI, Yuen NA, Ames M, Hunt CM. A pre-marketing ALT signal predicts post-marketing liver safety. Regulatory Toxicology and Pharmacology 2012;63:433-9. [DOI: 10.1016/j.yrtph.2012.05.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
542 Viana CF, Rocha TD, Cavalcante FP, Valença JT Jr, Coelho GR, Garcia JH. Liver transplantation for acute liver failure: a 5 years experience. Arq Gastroenterol 2008;45:192-4. [PMID: 18852944 DOI: 10.1590/s0004-28032008000300004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
543 Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. Species differences in bile acids I. Plasma and urine bile acid composition: Species Differences in Bile Acids I. In Vivo. J Appl Toxicol 2018;38:1323-35. [DOI: 10.1002/jat.3644] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
544 Powell CL, Kosyk O, Ross PK, Schoonhoven R, Boysen G, Swenberg JA, Heinloth AN, Boorman GA, Cunningham ML, Paules RS, Rusyn I. Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci 2006;93:213-22. [PMID: 16751229 DOI: 10.1093/toxsci/kfl030] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
545 Kim TS, Kim JM, Kwon CHD, Kim SJ, Joh JW, Lee SK. Prognostic Factors Predicting Poor Outcome in Living-Donor Liver Transplantation for Fulminant Hepatic Failure. Transplant Proc 2017;49:1118-22. [PMID: 28583539 DOI: 10.1016/j.transproceed.2017.03.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
546 Boonruamkaew P, Chonpathompikunlert P, Nagasaki Y. Redox Nanoparticle Therapeutics for Acetaminophen-Induced Hepatotoxicity in Mice. Oxid Med Cell Longev 2016;2016:4984597. [PMID: 27073589 DOI: 10.1155/2016/4984597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
547 Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481-489. [PMID: 16025496 DOI: 10.1002/hep.20800] [Cited by in Crossref: 393] [Cited by in F6Publishing: 335] [Article Influence: 24.6] [Reference Citation Analysis]
548 Ahmad A, Torrazza-Perez E, Schilsky ML. Liver transplantation for Wilson disease. Handb Clin Neurol 2017;142:193-204. [PMID: 28433103 DOI: 10.1016/B978-0-444-63625-6.00016-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
549 Redwood AJ, Pavlos RK, White KD, Phillips EJ. HLAs: Key regulators of T-cell-mediated drug hypersensitivity. HLA 2018;91:3-16. [PMID: 29171940 DOI: 10.1111/tan.13183] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 20.0] [Reference Citation Analysis]
550 de Ataide EC, Reges Perales S, Bastos Eloy da Costa L, Valerini FG, Shiyoiti Hirano E, Chueiri Neto F, Silveira Bello Stucchi R, de Fátima Santana Ferreira Boin I. Acute Liver Failure-25 Years at a Single Center: Role of Liver Transplantation in the Survival of Adult Patients. Transplant Proc 2018;50:472-5. [PMID: 29579830 DOI: 10.1016/j.transproceed.2018.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
551 Humayun F, Shehab TM, Tworek JA, Fontana RJ. A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report. J Med Case Rep. 2007;1:88. [PMID: 17877816 DOI: 10.1186/1752-1947-1-88] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
552 Thanapirom K, Treeprasertsuk S, Soonthornworasiri N, Poovorawan K, Chaiteerakij R, Komolmit P, Phaosawasdi K, Pinzani M. The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study. BMC Gastroenterol 2019;19:18. [PMID: 30691414 DOI: 10.1186/s12876-019-0935-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
553 Shone LP, King JP, Doane C, Wilson KM, Wolf MS. Misunderstanding and potential unintended misuse of acetaminophen among adolescents and young adults. J Health Commun 2011;16 Suppl 3:256-67. [PMID: 21951256 DOI: 10.1080/10810730.2011.604384] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
554 Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O'Grady J, Kim YJ. A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology. 2019;70:621-629. [PMID: 30194739 DOI: 10.1002/hep.30262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
555 Margulis E, Dagan-Wiener A, Ives RS, Jaffari S, Siems K, Niv MY. Intense bitterness of molecules: Machine learning for expediting drug discovery. Comput Struct Biotechnol J 2021;19:568-76. [PMID: 33510862 DOI: 10.1016/j.csbj.2020.12.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
556 Hunt CM, Forster JK, Papay JI, Stirnadel HA. Evidence-Based Liver Chemistry Monitoring in Drug Development. Pharm Med 2009;23:149-58. [DOI: 10.1007/bf03256763] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
557 Thompson RA, Isin EM, Ogese MO, Mettetal JT, Williams DP. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments. Chem Res Toxicol 2016;29:505-33. [DOI: 10.1021/acs.chemrestox.5b00410] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 15.8] [Reference Citation Analysis]
558 Li D, Fu YJ, Rusling JF. Characterizing protein modifications by reactive metabolites using magnetic bead bioreactors and LC-MS/MS. Chem Commun (Camb) 2015;51:4701-3. [PMID: 25693065 DOI: 10.1039/c5cc00420a] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
559 Stamper BD. Transcriptional profiling of reactive metabolites for elucidating toxicological mechanisms: a case study of quinoneimine-forming agents. Drug Metabolism Reviews 2015;47:45-55. [DOI: 10.3109/03602532.2014.978081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
560 Mahmud N. Selection for Liver Transplantation: Indications and Evaluation. Curr Hepatol Rep 2020;:1-10. [PMID: 32837824 DOI: 10.1007/s11901-020-00527-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
561 Lee WJ, Kim HW, Lee HY, Son CG. Systematic review on herb-induced liver injury in Korea. Food Chem Toxicol. 2015;84:47-54. [PMID: 26165727 DOI: 10.1016/j.fct.2015.06.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
562 Robert C, Saenz-feijoo R, Gaudy J, Arreto C. Quantitative analysis of the scientific literature on acetaminophen in medicine and biology: a 2003-2005 study. Fundamental & Clinical Pharmacology 2009;23:159-68. [DOI: 10.1111/j.1472-8206.2008.00655.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
563 Granitzny A, Knebel J, Müller M, Braun A, Steinberg P, Dasenbrock C, Hansen T. Evaluation of a human in vitro hepatocyte-NPC co-culture model for the prediction of idiosyncratic drug-induced liver injury: A pilot study. Toxicol Rep 2017;4:89-103. [PMID: 28959630 DOI: 10.1016/j.toxrep.2017.02.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
564 Yamashita YI, Imai K, Mima K, Nakagawa S, Hashimoto D, Chikamoto A, Baba H. Idiosyncratic drug-induced liver injury: A short review. Hepatol Commun. 2017;1:494-500. [PMID: 29404475 DOI: 10.1002/hep4.1064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
565 Paugam-burtz C, Levesque E, Louvet A, Thabut D, Amathieu R, Bureau C, Camus C, Chanques G, Faure S, Ferrandière M, Francoz C, Galbois A, Gustot T, Ichai C, Ichai P, Jaber S, Lescot T, Moreau R, Roullet S, Saliba F, Thévenot T, Velly L, Weiss E. Management of liver failure in general intensive care unit. Anaesthesia Critical Care & Pain Medicine 2020;39:143-61. [DOI: 10.1016/j.accpm.2019.06.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
566 Chan G, Taqi A, Marotta P, Levstik M, McAlister V, Wall W, Quan D. Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl. 2009;15:1696-1702. [PMID: 19938124 DOI: 10.1002/lt.21931] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
567 Wancket LM, Meng X, Rogers LK, Liu Y. Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury. Toxicol Pathol 2012;40:1095-105. [PMID: 22623522 DOI: 10.1177/0192623312447551] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
568 O'Brien CB. The hospitalized patient with abnormal liver function tests. Clin Liver Dis 2009;13:179-92. [PMID: 19442913 DOI: 10.1016/j.cld.2009.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
569 Holman NS, Mosedale M, Wolf KK, LeCluyse EL, Watkins PB. Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury? Toxicol Sci. 2016;151:365-375. [PMID: 26962055 DOI: 10.1093/toxsci/kfw047] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
570 Shaw PJ, Hopfensperger MJ, Ganey PE, Roth RA. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci 2007;100:259-66. [PMID: 17709330 DOI: 10.1093/toxsci/kfm218] [Cited by in Crossref: 113] [Cited by in F6Publishing: 94] [Article Influence: 8.1] [Reference Citation Analysis]
571 Zhang Q, Guo X, Zhao S, Pang X, Wang Y, Zhang Y, Chi B. Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients. Exp Ther Med 2016;11:1348-54. [PMID: 27073448 DOI: 10.3892/etm.2016.3037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
572 Al Mutairi F, Dwivedi G, Al Ameel T. Fulminant hepatic failure in association with quetiapine: a case report. J Med Case Rep. 2012;6:418. [PMID: 23234465 DOI: 10.1186/1752-1947-6-418] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
573 Ramos R, Mascarenhas J, Duarte P, Vicente C, Casteleiro C. Conjugated linoleic acid-induced toxic hepatitis: first case report. Dig Dis Sci 2009;54:1141-3. [PMID: 18720003 DOI: 10.1007/s10620-008-0461-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
574 MacDonald AJ, Speiser JL, Ganger DR, Nilles KM, Orandi BJ, Larson AM, Lee WM, Karvellas CJ; US Acute Liver Failure Study Group. Clinical and Neurologic Outcomes in Acetaminophen-Induced Acute Liver Failure: A 21-Year Multicenter Cohort Study. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31273-8. [PMID: 32920216 DOI: 10.1016/j.cgh.2020.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
575 Khanal S, Ghimire P, Dhamoon AS. Liver Injury During Treatment With Rifampicin, Vancomycin, and Acetaminophen. American Journal of Therapeutics 2018;25:e735-7. [DOI: 10.1097/mjt.0000000000000749] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
576 Abid A, Subhani F, Kayani F, Awan S, Abid S. Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan. PLoS One 2020;15:e0231398. [PMID: 32276267 DOI: 10.1371/journal.pone.0231398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
577 Petronijevic M, Ilic K, Suzuki A. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database: REPORTING OF HEPATOTOXICITY IN SERBIA. Pharmacoepidem Drug Safe 2011;20:416-23. [DOI: 10.1002/pds.2115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
578 Borlak J, Chatterji B, Londhe KB, Watkins PB. Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury. Genome Med 2013;5:86. [PMID: 24070255 DOI: 10.1186/gm493] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
579 Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, Chung RT, Lee WM, Fontana RJ. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci. 2012;57:777-785. [PMID: 21948394 DOI: 10.1007/s10620-011-1918-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
580 Sivilotti ML, Yarema MC, Juurlink DN, Good AM, Johnson DW. A Risk Quantification Instrument for Acute Acetaminophen Overdose Patients Treated With N-Acetylcysteine. Annals of Emergency Medicine 2005;46:263-71. [DOI: 10.1016/j.annemergmed.2005.04.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
581 Jemnitz K, Veres Z, Monostory K, Kóbori L, Vereczkey L. Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes. Toxicol In Vitro 2008;22:961-7. [PMID: 18346862 DOI: 10.1016/j.tiv.2008.02.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
582 Zheng N, Gu Y, Hong Y, Sheng L, Chen L, Zhang F, Hou J, Zhang W, Zhang Z, Jia W, Li H. Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid. J Pharm Anal 2020;10:560-70. [PMID: 33425450 DOI: 10.1016/j.jpha.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
583 Baudy AR, Otieno MA, Hewitt P, Gan J, Roth A, Keller D, Sura R, Van Vleet TR, Proctor WR. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab Chip 2020;20:215-25. [DOI: 10.1039/c9lc00768g] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 31.0] [Reference Citation Analysis]
584 Feld JJ, Liang TJ. Hepatitis C — identifying patients with progressive liver injury. Hepatology 2006;43:S194-206. [DOI: 10.1002/hep.21065] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
585 Zaky HS, Gad AM, Nemr E, Hassan W, Abd El-Raouf OM, Ali AA. Modulatory effects of some natural products on hepatotoxicity induced by combination of sodium valproate and paracetamol in rats. J Biochem Mol Toxicol 2018;:e22162. [PMID: 29799656 DOI: 10.1002/jbt.22162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
586 Weinstein RB, Schuemie MJ, Ryan PB, Stang PE. Seasonality in acute liver injury? Findings in two health care claims databases. Drug Healthc Patient Saf 2016;8:39-48. [PMID: 27099532 DOI: 10.2147/DHPS.S95399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
587 Chia AJ, Goldring CE, Kitteringham NR, Wong SQ, Morgan P, Park BK. Differential effect of covalent protein modification and glutathione depletion on the transcriptional response of Nrf2 and NF-kappaB. Biochem Pharmacol 2010;80:410-21. [PMID: 20416283 DOI: 10.1016/j.bcp.2010.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
588 Chung HS, Jung DH, Park CS. Intraoperative predictors of short-term mortality in living donor liver transplantation due to acute liver failure. Transplant Proc. 2013;45:236-240. [PMID: 23375307 DOI: 10.1016/j.transproceed.2012.06.077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
589 Hadem J, Schneider AS, Manns MP. [Acute liver failure. How much diagnostic work-up and therapy does my patient need?]. Internist (Berl) 2011;52:804, 806-8, 810-4. [PMID: 21713607 DOI: 10.1007/s00108-010-2793-0] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
590 Licata A. Adverse drug reactions and organ damage: The liver. Eur J Intern Med. 2016;28:9-16. [PMID: 26827101 DOI: 10.1016/j.ejim.2015.12.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 8.4] [Reference Citation Analysis]
591 Murphy D, Khan A, Borscheid C, Riad S. A quarter pound of acetaminophen with propylene glycol on the side: A case report. Clin Nephrol Case Stud 2020;8:62-6. [PMID: 32905357 DOI: 10.5414/CNCS109936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
592 Bushel PR, Fannin RD, Gerrish K, Watkins PB, Paules RS. Blood gene expression profiling of an early acetaminophen response. Pharmacogenomics J 2017;17:230-6. [PMID: 26927286 DOI: 10.1038/tpj.2016.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
593 Court MH, Freytsis M, Wang X, Peter I, Guillemette C, Hazarika S, Duan SX, Greenblatt DJ, Lee WM; Acute Liver Failure Study Group. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther 2013;345:297-307. [PMID: 23408116 DOI: 10.1124/jpet.112.202010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
594 Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39:1906-17. [PMID: 31319011 DOI: 10.1111/liv.14195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
595 Bunchorntavakul C, Reddy KR. Acetaminophen-related hepatotoxicity. Clin Liver Dis. 2013;17:587-607, viii. [PMID: 24099020 DOI: 10.1016/j.cld.2013.07.005] [Cited by in Crossref: 134] [Cited by in F6Publishing: 104] [Article Influence: 16.8] [Reference Citation Analysis]
596 Mainardi V, Rando K, Valverde M, Olivari D, Castelli J, Rey G, Gerona S. Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay. Ann Hepatol. 2019;18:187-192. [PMID: 31113589 DOI: 10.5604/01.3001.0012.7911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
597 Ghanem CI, Manautou JE. Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics. Curr Med Chem 2019;26:1185-223. [PMID: 29473496 DOI: 10.2174/0929867325666180221142315] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
598 Kumar BS, Chung BC, Kwon OS, Jung BH. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J Appl Toxicol 2012;32:505-20. [PMID: 22131085 DOI: 10.1002/jat.1746] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
599 Fahy BN, Guo T, Ghose R. Impact of hepatic malignancy on CYP3A4 gene expression. J Surg Res 2012;178:768-72. [PMID: 22763214 DOI: 10.1016/j.jss.2012.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
600 Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, Hoofnagle JH. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010;52:730-42. [PMID: 20564754 DOI: 10.1002/hep.23696] [Cited by in Crossref: 191] [Cited by in F6Publishing: 167] [Article Influence: 17.4] [Reference Citation Analysis]
601 Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology. 2008;48:1577-1585. [PMID: 18925633 DOI: 10.1002/hep.22493] [Cited by in Crossref: 133] [Cited by in F6Publishing: 106] [Article Influence: 10.2] [Reference Citation Analysis]
602 Wong A, Sivilotti MLA, Gunja N, McNulty R, Graudins A. Accuracy of the paracetamol-aminotransferase product to predict hepatotoxicity in paracetamol overdose treated with a 2-bag acetylcysteine regimen. Clin Toxicol (Phila) 2018;56:182-8. [PMID: 28756679 DOI: 10.1080/15563650.2017.1355058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
603 Hadi M, Westra IM, Starokozhko V, Dragovic S, Merema MT, Groothuis GM. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol. 2013;26:710-720. [PMID: 23565644 DOI: 10.1021/tx300519p] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
604 Bunchorntavakul C, Reddy KR. Acute Liver Failure. Clinics in Liver Disease 2017;21:769-92. [DOI: 10.1016/j.cld.2017.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
605 Simmons OL, Meinzer C, Rule J, Lee WM; Acute Liver Failure Study Group. Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes. Dig Dis Sci 2020;65:1861-8. [PMID: 31679087 DOI: 10.1007/s10620-019-05901-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
606 Steuerwald NM, Foureau DM, Norton HJ, Zhou J, Parsons JC, Chalasani N, Fontana RJ, Watkins PB, Lee WM, Reddy KR. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One. 2013;e81974. [PMID: 24386086 DOI: 10.1371/journal.pone.0081974] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
607 Møller HJ, Grønbaek H, Schiødt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T, Lee WM. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol. 2007;47:671-676. [PMID: 17629586 DOI: 10.1016/j.jhep.2007.05.014] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 7.7] [Reference Citation Analysis]
608 Zimmerman JJ, Patat A, Parks V, Moirand R, Matschke K. Pharmacokinetics of sirolimus (rapamycin) in subjects with severe hepatic impairment. J Clin Pharmacol 2008;48:285-92. [PMID: 18218785 DOI: 10.1177/0091270007312902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
609 Kleiner DE. Liver Injury Due to Drugs and Herbal Agents. Practical Hepatic Pathology: a Diagnostic Approach. Elsevier; 2018. pp. 327-70. [DOI: 10.1016/b978-0-323-42873-6.00023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
610 Miyakawa K, Joshi N, Sullivan BP, Albee R, Brandenberger C, Jaeschke H, McGill MR, Scott MA, Ganey PE, Luyendyk JP, Roth RA. Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice. Blood 2015;126:1835-43. [PMID: 26179083 DOI: 10.1182/blood-2014-09-598656] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
611 Yeoman AD, Westbrook RH, Zen Y, Bernal W, Al-Chalabi T, Wendon JA, O'Grady JG, Heneghan MA. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol 2014;61:876-82. [PMID: 24842305 DOI: 10.1016/j.jhep.2014.05.021] [Cited by in Crossref: 88] [Cited by in F6Publishing: 69] [Article Influence: 12.6] [Reference Citation Analysis]
612 Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E. Serum apoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol. 2007;5:1477-1483. [PMID: 17967565 DOI: 10.1016/j.cgh.2007.08.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
613 Dai C, Ma S, Wang F, Zhao H, Wu X, Huang Z, Chen Z, To K, Fu L. Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes. Oncotarget 2015;6:17738-52. [PMID: 26036634 DOI: 10.18632/oncotarget.3921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
614 Huang X, Shao L, Gong Y, Mao Y, Liu C, Qu H, Cheng Y. A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC/MS metabolic profiles of plasma in mice. J Chromatogr B Analyt Technol Biomed Life Sci 2008;870:178-85. [PMID: 18602877 DOI: 10.1016/j.jchromb.2008.05.049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
615 Toyoda Y, Miyashita T, Endo S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Estradiol and progesterone modulate halothane-induced liver injury in mice. Toxicology Letters 2011;204:17-24. [DOI: 10.1016/j.toxlet.2011.03.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
616 Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009;29:337-347. [PMID: 19826967 DOI: 10.1055/s-0029-1240002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 100] [Article Influence: 10.5] [Reference Citation Analysis]
617 Xu D, Wu M, Nishimura S, Nishimura T, Michie SA, Zheng M, Yang Z, Yates AJ, Day JS, Hillgren KM. Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity. J Pharmacol Exp Ther. 2015;352:274-280. [PMID: 25424997 DOI: 10.1124/jpet.114.220798] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
618 Yu L, Zhao XK, Cheng ML, Yang GZ, Wang B, Liu HJ, Hu YX, Zhu LL, Zhang S, Xiao ZW, Liu YM, Zhang BF, Mu M. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Sci Rep 2017;7:1359. [PMID: 28465509 DOI: 10.1038/s41598-017-01271-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
619 Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4:489-499. [PMID: 15931258 DOI: 10.1038/nrd1750] [Cited by in Crossref: 738] [Cited by in F6Publishing: 603] [Article Influence: 46.1] [Reference Citation Analysis]
620 Ghanem CI, Pérez MJ, Manautou JE, Mottino AD. Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacol Res 2016;109:119-31. [PMID: 26921661 DOI: 10.1016/j.phrs.2016.02.020] [Cited by in Crossref: 131] [Cited by in F6Publishing: 89] [Article Influence: 26.2] [Reference Citation Analysis]
621 Lee WM. The case for limiting acetaminophen-related deaths: smaller doses and unbundling the opioid-acetaminophen compounds. Clin Pharmacol Ther 2010;88:289-92. [PMID: 20725075 DOI: 10.1038/clpt.2010.164] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
622 Kozer E, Greenberg R, Zimmerman D, Berkovitch M. Repeated supratherapeutic doses of paracetamol in children—a literature review and suggested clinical approach. Acta Paediatrica 2006;95:1165-71. [DOI: 10.1080/08035250600580503] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
623 Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C. Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS). Pharmacoepidemiol Drug Saf 2021;30:320-33. [PMID: 33099844 DOI: 10.1002/pds.5161] [Reference Citation Analysis]
624 Hedrington MS, Davis SN. Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver. Expert Opin Drug Metab Toxicol 2018;14:671-7. [PMID: 29847748 DOI: 10.1080/17425255.2018.1483337] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
625 Guler N, Unalp O, Guler A, Yaprak O, Dayangac M, Sozbilen M, Akyildiz M, Tokat Y. Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure. Hepatobiliary & Pancreatic Diseases International 2013;12:589-93. [DOI: 10.1016/s1499-3872(13)60093-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
626 Shen JX, Youhanna S, Zandi Shafagh R, Kele J, Lauschke VM. Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity. Chem Res Toxicol 2020;33:38-60. [DOI: 10.1021/acs.chemrestox.9b00245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
627 Lo C. Liver transplantation for acute liver failure: Not too early but never too late. Liver Transpl 2008;14:1243-4. [DOI: 10.1002/lt.21536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
628 Coté GA, Gottstein JH, Daud A, Blei AT; Acute Liver Failure Study Group. The role of etiology in the hyperamylasemia of acute liver failure. Am J Gastroenterol 2009;104:592-7. [PMID: 19223884 DOI: 10.1038/ajg.2008.84] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
629 Kancherla D, Gajendran M, Vallabhaneni P, Vipperla K. Metronidazole induced liver injury: a rare immune mediated drug reaction. Case Rep Gastrointest Med 2013;2013:568193. [PMID: 24455335 DOI: 10.1155/2013/568193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
630 Hunt CM, Yuen NA, Stirnadel-Farrant HA, Suzuki A. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Regul Toxicol Pharmacol. 2014;70:519-526. [PMID: 25236535 DOI: 10.1016/j.yrtph.2014.09.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
631 Goldaracena N, Spetzler VN, Marquez M, Selzner N, Cattral MS, Greig PD, Lilly L, Mcgilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M. Live Donor Liver Transplantation: A Valid Alternative for Critically Ill Patients Suffering From Acute Liver Failure: Live Donor Transplant for Acute Liver Failure. American Journal of Transplantation 2015;15:1591-7. [DOI: 10.1111/ajt.13203] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
632 Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet. 2007;369:397-408. [PMID: 17276780 DOI: 10.1016/s0140-6736(07)60196-2] [Cited by in Crossref: 660] [Cited by in F6Publishing: 183] [Article Influence: 47.1] [Reference Citation Analysis]
633 Björnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scandinavian Journal of Gastroenterology 2009;40:1095-101. [DOI: 10.1080/00365520510023846] [Cited by in Crossref: 94] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
634 Lakshmi T, Sri Renukadevi B, Senthilkumar S, Haribalan P, Parameshwari R, Vijayaraghavan R, Rajeshkumar S. Seed and bark extracts of Acacia catechu protects liver from acetaminophen induced hepatotoxicity by modulating oxidative stress, antioxidant enzymes and liver function enzymes in Wistar rat model. Biomed Pharmacother 2018;108:838-44. [PMID: 30372895 DOI: 10.1016/j.biopha.2018.08.077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
635 Huang W, Whittaker K, Zhang H, Wu J, Zhu S, Huang R. Integration of Antibody Array Technology into Drug Discovery and Development. ASSAY and Drug Development Technologies 2018;16:74-95. [DOI: 10.1089/adt.2017.808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
636 Wei G, Kalaitzakis E, Bergquist A, Björnsson E. Long-term follow-up of patients with acute liver failure of indeterminate aetiology. Scand J Gastroenterol 2008;43:984-91. [PMID: 19086167 DOI: 10.1080/00365520801965399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
637 Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31-41. [PMID: 30003672 DOI: 10.1111/liv.13931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
638 Kakisaka K, Takikawa Y. Elevation of serum cytokines preceding elevation of liver enzymes in a case of drug-induced liver injury. Hepatol Res. 2013;44:E284-E289. [PMID: 24119001 DOI: 10.1111/hepr.12253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
639 Rutherford A, Davern T, Hay JE, Murray NG, Hassanein T, Lee WM, Chung RT. Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol. 2006;4:1544-1549. [PMID: 16996806 DOI: 10.1016/j.cgh.2006.07.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
640 Lv H, Liu L, Zhang Y, Song T, Lu J, Chen X. Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs. Mol Biosyst 2010;6:2056-67. [PMID: 20714645 DOI: 10.1039/c0mb00064g] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
641 Dugan CM, Fullerton AM, Roth RA, Ganey PE. Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis. Toxicol Sci 2011;120:507-18. [PMID: 21245496 DOI: 10.1093/toxsci/kfr005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
642 Vliegenthart AD, Antoine DJ, Dear JW. Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol 2015;80:351-62. [PMID: 26076366 DOI: 10.1111/bcp.12699] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
643 Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int 2011;108:714-20. [PMID: 22114640 DOI: 10.3238/arztebl.2011.0714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
644 Rangnekar AS, Ellerbe C, Durkalski V, McGuire B, Lee WM, Fontana RJ. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transpl 2013;19:991-1000. [PMID: 23780824 DOI: 10.1002/lt.23688] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
645 Grewal J, Doan A, Hong AS, Amin A, Scapa JV, Hanna R, Durazo F, Yanny B. Drug-Induced Autoimmune Hepatitis From Hydralazine Leading to Acute Liver Failure and Liver Transplantation. ACG Case Rep J 2019;6:e00252. [PMID: 31832473 DOI: 10.14309/crj.0000000000000252] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
646 Clare KE, Miller MH, Dillon JF. Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis? Curr Hepatol Rep 2017;16:258-64. [PMID: 28856081 DOI: 10.1007/s11901-017-0363-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
647 Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806-815. [PMID: 21544079 DOI: 10.1038/clpt.2011.58] [Cited by in Crossref: 495] [Cited by in F6Publishing: 415] [Article Influence: 49.5] [Reference Citation Analysis]
648 Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006;44:1581-8. [PMID: 17133470 DOI: 10.1002/hep.21424] [Cited by in Crossref: 197] [Cited by in F6Publishing: 162] [Article Influence: 14.1] [Reference Citation Analysis]
649 Elinav E, Ben-Dov I, Hai-Am E, Ackerman Z, Ofran Y. The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. J Hepatol. 2005;42:82-86. [PMID: 15629511 DOI: 10.1016/j.jhep.2004.09.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
650 Giordano CM, Zervos XB. Clinical Manifestations and Treatment of Drug-induced Hepatotoxicity. Clinics in Liver Disease 2013;17:565-73. [DOI: 10.1016/j.cld.2013.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
651 Craig DG, Lee A, Hayes PC, Simpson KJ. Review article: the current management of acute liver failure. Aliment Pharmacol Ther. 2010;31:345-358. [PMID: 19845566 DOI: 10.1111/j.1365-2036.2009.04175.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
652 Takikawa Y, Endo R, Suzuki K, Tsubouchi H. Early prediction of short-term development of hepatic encephalopathy in patients with acute liver disease unrelated to paracetamol. A prospective study in Japan. J Hepatol. 2009;51:1021-1029. [PMID: 19864034 DOI: 10.1016/j.jhep.2009.09.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
653 Fujiwara K, Yasui S, Tawada A, Okitsu K, Yonemitsu Y, Chiba T, Arai M, Kanda T, Imazeki F, Nakano M. Autoimmune fulminant liver failure in adults: Experience in a Japanese center. Hepatol Res. 2011;41:133-141. [PMID: 21269383 DOI: 10.1111/j.1872-034x.2010.00755.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
654 Fang WY, Abuduxikuer K, Shi P, Qiu YL, Zhao J, Li YC, Zhang XY, Wang NL, Xie XB, Lu Y, Knisely AS, Wang JS. Pediatric Wilson disease presenting as acute liver failure: Prognostic indices. World J Clin Cases 2021;9:3273-86. [PMID: 34002136 DOI: 10.12998/wjcc.v9.i14.3273] [Reference Citation Analysis]
655 Parekh NK, Hynan LS, De Lemos J, Lee WM; Acute Liver Failure Study Group. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology 2007;45:1489-95. [PMID: 17538968 DOI: 10.1002/hep.21640] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
656 Vitins AP, Kienhuis AS, Speksnijder EN, Roodbergen M, Luijten M, van der Ven LT. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models. Arch Toxicol 2014;88:1573-88. [PMID: 24535564 DOI: 10.1007/s00204-014-1211-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
657 Vandriel SM, Ayoub MD, Ricciuto A, Hansen BE, Ling SC, Ng VL, Roberts EA, Kamath BM. Pediatric Wilson Disease Presenting as Acute Liver Failure: An Individual Patient Data Meta-analysis. Journal of Pediatric Gastroenterology & Nutrition 2020;71:e90-6. [DOI: 10.1097/mpg.0000000000002777] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
658 Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Nakano M, Oda S, Yokosuka O. Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria. J Hepatobiliary Pancreat Sci 2015;22:225-9. [PMID: 25339364 DOI: 10.1002/jhbp.178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
659 Boudreau DM, Wirtz H, Von Korff M, Catz SL, St John J, Stang PE. A survey of adult awareness and use of medicine containing acetaminophen. Pharmacoepidemiol Drug Saf 2013;22:229-40. [PMID: 22890688 DOI: 10.1002/pds.3335] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
660 Joshi GP. Multimodal analgesia techniques for ambulatory surgery. Int Anesthesiol Clin 2005;43:197-204. [PMID: 15970757 DOI: 10.1097/01.aia.0000166336.69251.dd] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
661 Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, Park BJ, Park JW, Hong CS. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci 2012;27:268-73. [PMID: 22379337 DOI: 10.3346/jkms.2012.27.3.268] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
662 Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR. Using controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology 2008;48:1680-9. [PMID: 18853438 DOI: 10.1002/hep.22633] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
663 Aminoshariae A, Khan A. Acetaminophen: old drug, new issues. J Endod 2015;41:588-93. [PMID: 25732401 DOI: 10.1016/j.joen.2015.01.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
664 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914-928. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 147] [Cited by in F6Publishing: 119] [Article Influence: 18.4] [Reference Citation Analysis]
665 Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol 2014;60:872-84. [PMID: 24280292 DOI: 10.1016/j.jhep.2013.11.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
666 Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol. 2017;9:491-502. [PMID: 28443154 DOI: 10.4254/wjh.v9.i10.491] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
667 Nikkilä K, Nissinen MJ, Gylling H, Isoniemi H, Miettinen TA. Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation. J Hepatol. 2008;49:936-945. [PMID: 18926587 DOI: 10.1016/j.jhep.2008.07.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
668 Pannu AK, Bhalla A, Rao C, Singh C. Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure. Int J Crit Illn Inj Sci 2017;7:252-5. [PMID: 29291180 DOI: 10.4103/IJCIIS.IJCIIS_122_16] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
669 Shah I, Putnam T, Daugherty E, Vyas N, Chuang KY. Mifepristone: An Uncommon Cause of Drug-Induced Liver Injury. Gastroenterology Res 2019;12:181-4. [PMID: 31236162 DOI: 10.14740/gr1188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
670 Palmes D, Skawran S, Stratmann U, Armann B, Minin E, Herbst H, Spiegel HU. Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure. J Hepatol. 2005;42:350-357. [PMID: 15710217 DOI: 10.1016/j.jhep.2004.11.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
671 Dallak M, Dawood AF, Haidara MA, Abdel Kader DH, Eid RA, Kamar SS, Shams Eldeen AM, Al-Ani B. Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin. Drug Chem Toxicol 2020;:1-7. [PMID: 32013615 DOI: 10.1080/01480545.2020.1722156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
672 Camus C, Lavoué S, Gacouin A, Le Tulzo Y, Lorho R, Boudjéma K, Jacquelinet C, Thomas R. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006;32:1817-25. [PMID: 16941171 DOI: 10.1007/s00134-006-0340-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
673 Germani G, Battistella S, Ulinici D, Zanetto A, Shalaby S, Pellone M, Gambato M, Senzolo M, Russo FP, Burra P. Drug induced liver injury: from pathogenesis to liver transplantation. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.20.02795-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
674 Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M; Acute Liver Failure Study Group. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol 2018;16:936-46. [PMID: 29199145 DOI: 10.1016/j.cgh.2017.11.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
675 Seife Hassen S, Ata F, Bint I Bilal A, Salih Ali M, Petkar M, Awad Elzouki AY, Zahid M. Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clin Case Rep 2020;8:3421-6. [PMID: 33363945 DOI: 10.1002/ccr3.3421] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
676 Li P, Li S, Gu H, Lu Q, Jiang W, Pei X, Sun Y, Xu H, Wang G, Hao K. The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice. Biomedicine & Pharmacotherapy 2018;97:1000-10. [DOI: 10.1016/j.biopha.2017.10.158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
677 Totsugawa T, Yong C, Rivas-Carrillo JD, Soto-Gutierrez A, Navarro-Alvarez N, Noguchi H, Okitsu T, Westerman KA, Kohara M, Reth M. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J Hepatol. 2007;47:74-82. [PMID: 17434229 DOI: 10.1016/j.jhep.2007.02.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
678 Fikatas P, Lee JE, Sauer IM, Schmidt SC, Seehofer D, Puhl G, Guckelberger O. APACHE III score is superior to King’s College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure. Transplant Proc. 2013;45:2295-2301. [PMID: 23953541 DOI: 10.1016/j.transproceed.2013.02.125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
679 Lucena MI, Cohen H, Hernández N, Bessone F, Dacoll C, Stephens C, Borraz Y, Ulzurrun E, Bruguera M, Andrade RJ. Hepatotoxicidad, un problema global con especificidades locales: hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad. Gastroenterología y Hepatología 2011;34:361-8. [DOI: 10.1016/j.gastrohep.2011.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
680 Yuan XZ, Yang RM, Wang XP. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy. Curr Neuropharmacol 2021;19:465-85. [PMID: 32351182 DOI: 10.2174/1570159X18666200429233517] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
681 Fannin RD, Russo M, O'Connell TM, Gerrish K, Winnike JH, Macdonald J, Newton J, Malik S, Sieber SO, Parker J, Shah R, Zhou T, Watkins PB, Paules RS. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 2010;51:227-36. [PMID: 19918972 DOI: 10.1002/hep.23330] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
682 Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006;15:398-405. [PMID: 16294364 DOI: 10.1002/pds.1191] [Cited by in Crossref: 189] [Cited by in F6Publishing: 159] [Article Influence: 12.6] [Reference Citation Analysis]
683 Russo MW. Current concepts in the evaluation of patients for liver transplantation. Expert Review of Gastroenterology & Hepatology 2014;1:307-20. [DOI: 10.1586/17474124.1.2.307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
684 Urrunaga NH, Jadeja RN, Rachakonda V, Ahmad D, McLean LP, Cheng K, Shah V, Twaddell WS, Raufman JP, Khurana S. M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury. Free Radic Biol Med 2015;78:66-81. [PMID: 25452146 DOI: